Dr. Vicente Soriano

All Stories

1. 
   Is the HIV-2 pandemic going extinct 40 years after virus discovery?

   Article • Journal of Microbiology Immunology and Infection, July 2026, Elsevier

   Dr. Vicente Soriano

2. 
   Infection With Human T‐Lymphotropic Virus 1 (HTLV‐1) in Ivory Coast

   Article • Journal of Medical Virology, March 2026, Wiley

   Dr. Vicente Soriano

3. 
   Hospitalizations in adolescents with autism spectrum disorder are rising in Spain

   Article • Child and Adolescent Psychiatry and Mental Health, March 2026, Springer Science + Business Media

   Dr. Vicente Soriano

4. 
   Occult hepatitis B infection – unveiling clinical burden and new diagnostic strategies

   Article • Expert Review of Gastroenterology & Hepatology, January 2026, Taylor & Francis

   Dr. Vicente Soriano

5. 
   Cloning and editing of animals for human benefit

   Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

   Dr. Vicente Soriano

6. 
   New CDC guidelines for HIV post-exposure prophylaxis

   Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

   Dr. Vicente Soriano

7. 
   Human ecology: a bridge between medical ethics and the 2030 Agenda

   Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

   Dr. Vicente Soriano

8. 
   Is the HIV-2 pandemic vanishing?

   Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

   Dr. Vicente Soriano

9. 
   Rising in Listeria monocytogenes infection – any risk for persons living with HIV?

   Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

   Dr. Vicente Soriano

10. 
    Sexually transmitted infections keep rising up

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

11. 
    International HTLV Conference, London, June 3-5, 2024

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

12. 
    Obelisks Ó Newly discovered virus-like particles

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

13. 
    On the origin of life on earth

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

14. 
    Strengthen the doctor-patient relationship and avoid administrative stifling

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

15. 
    The burden of HIV-1 and HIV-2 epidemics in Ivory Coast

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

16. 
    The new face of advanced HIV infection

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

17. 
    The origin of the four major focus of HTLV-1 in Latin America

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

18. 
    The risk for pandemic avian influenza

    Article • Aids Reviews, December 2025, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

19. 
    Sharp rise in hospital admissions for depression in Spanish adolescents over 20 years

    Article • Journal of Affective Disorders, November 2025, Elsevier

    Lucia Gallego Deike, Dr. Vicente Soriano

20. 
    The cascade of care for hepatitis B – any lessons from the HIV field?

    Article • Expert Review of Anti-infective Therapy, October 2025, Taylor & Francis

    Dr. Vicente Soriano

21. 
    High Rate of Human T-Cell Lymphotropic Virus-2 in Patients with HIV in the Peruvian Amazon

    Article • Tropical Medicine and Infectious Disease, September 2025, MDPI AG

    Dr. Vicente Soriano

22. 
    High Rate of Co-Infection with Human T-Cell Lymphotropic Virus-2 in Patients with HIV in the Peruvian Amazon

    Article • August 2025, MDPI AG

    Dr. Vicente Soriano

23. 
    Sex-Specific Diagnostic Subtypes in Adolescents Hospitalized for Substance Use Disorders Revealed by Transformer-Based Clustering

    Article • August 2025, openRxiv

    Dr. Vicente Soriano

24. 
    Hospitalizations in adolescents with anorexia nervosa in Spain over two decades

    Article • Journal of Eating Disorders, July 2025, Springer Science + Business Media

    Dr. Vicente Soriano, Lucia Gallego Deike

25. 
    Hospitalisations With Cryoglobulin‐Related Diseases in Spain Over 25 Years

    Article • Liver International, June 2025, Wiley

    Dr. Vicente Soriano

26. 
    Molecular Diagnosis in Hymenoptera Allergy: Comparison of Euroline DPA-Dx and ImmunoCAP

    Article • Toxins, June 2025, MDPI AG

    Dr. Vicente Soriano

27. 
    Cross-jurisdictional factors linked to gambling frequency in adolescents from 28 European countries: a machine learning approach

    Article • Psychiatry Research, June 2025, Elsevier

    sabrina molinaro, Dr. Vicente Soriano

28. 
    Suicide risk within 30 days after emergency department discharge in adults

    Article • Internal and Emergency Medicine, April 2025, Springer Science + Business Media

    Dr. Vicente Soriano, Lucia Gallego Deike

29. 
    Trends in Suicidal Behavior Among Adolescents Hospitalized in Spain Over the Past Two Decades

    Article • Journal of Affective Disorders, October 2024, Elsevier

    Octavio Corral Pazos de Provens, Dr. Vicente Soriano, Lucia Gallego Deike

30. 
    Hospital Admissions for Mental Disorders in Adolescents in Spain

    Article • European Child & Adolescent Psychiatry, August 2024, Springer Science + Business Media

    Octavio Corral Pazos de Provens, Dr. Vicente Soriano, Lucia Gallego Deike

31. 
    Increased Cases and Deaths from Listeria Infections in Spain

    Article • International Journal of Infectious Diseases, August 2024, Elsevier

    Dr. Vicente Soriano, Octavio Corral Pazos de Provens

32. 
    Influence of inputs from foreign source regions on daily profiles of Olea pollen at an urban site in the southeast of the Iberian Peninsula

    Article • Atmospheric Environment, August 2024, Elsevier

    Dr. Vicente Soriano

33. 
    Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

    Article • Gigabyte, June 2024, GigaScience Press

    Dr. Vicente Soriano

34. 
    Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta-analysis

    Article • International Journal of Infectious Diseases, June 2024, Elsevier

    Dr. Vicente Soriano

35. 
    COVID-19 mortality amongst the immunosuppresed

    Article • Journal of Infection, April 2024, Elsevier

    Dr. Vicente Soriano

36. 
    Prospects for Controlling Hepatitis B Globally

    Article • Pathogens, March 2024, MDPI AG

    Dr. Vicente Soriano

37. 
    Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

    Article • IJID Regions, March 2024, Elsevier

    Dr. Vicente Soriano

38. 
    Screening for HTLV-1 infection should be expanded in Europe

    Article • International Journal of Infectious Diseases, February 2024, Elsevier

    Dr. Vicente Soriano

39. 
    Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

    Article • January 2024, Cold Spring Harbor Laboratory Press

    Dr. Vicente Soriano

40. 
    Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

    Article • NeuroImmune Pharmacology and Therapeutics, January 2024, De Gruyter

    Dr. Vicente Soriano

41. 
    �One Health�: toward an integral ecology of health

    Article • Aids Reviews, January 2024, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

42. 
    Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    Article • Aids Reviews, January 2024, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

43. 
    Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization

    Article • Scientific Reports, December 2023, Springer Science + Business Media

    Dr. Vicente Soriano

44. 
    HTLV infection in persons with sexually transmitted diseases in Spain

    Article • Frontiers in Immunology, December 2023, Frontiers

    Dr. Vicente Soriano

45. 
    HTLV-1-associated myelopathy in Spain

    Article • Journal of Clinical Virology, December 2023, Elsevier

    Dr. Vicente Soriano

46. 
    Triple Threat: HDV, HBV, HIV Coinfection

    Article • Clinics in Liver Disease, November 2023, Elsevier

    Dr. Vicente Soriano

47. 
    HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection

    Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

48. 
    Mitochondrial damage as cause of long COVID

    Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

49. 
    Rebound in sexually transmitted infections after the COVID-19 pandemic

    Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

50. 
    Genetic Changes in T Cell Receptors May Explain Severe COVID-19 Cases

    Article • iScience, October 2023, Elsevier

    Professor Jose M Martin-Villa, Dr. Vicente Soriano, Octavio Corral Pazos de Provens

51. 
    Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Article • Journal of Clinical Virology, October 2023, Elsevier

    Dr. Vicente Soriano

52. 
    Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Article • Journal of Clinical Virology, October 2023, Elsevier

    Dr. Vicente Soriano

53. 
    Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

    Article • Cancers, September 2023, MDPI AG

    Dr. Vicente Soriano

54. 
    Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection

    Article • Advanced Drug Delivery Reviews, September 2023, Elsevier

    Dr. Vicente Soriano

55. 
    Current Challenges for Conscientious Objection by Physicians in Spain

    Article • The Linacre Quarterly, August 2023, SAGE Publications

    Dr. Vicente Soriano

56. 
    Mental Health Crisis in the Youth and Rebound in Sexually Transmitted Infections

    Article • Aids Reviews, August 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

57. 
    The use of �sex� and �gender� in medical research

    Article • Aids Reviews, July 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

58. 
    Correction to: Predictors of in-hospital mortality in HIV-infected patients with COVID-19

    Article • QJM, June 2023, Oxford University Press (OUP)

    Dr. Vicente Soriano

59. 
    Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

    Article • International Journal of Infectious Diseases, June 2023, Elsevier

    Dr. Vicente Soriano

60. 
    Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

    Article • Autoimmunity Reviews, June 2023, Elsevier

    Dr. Vicente Soriano

61. 
    Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence

    Article • QJM, May 2023, Oxford University Press (OUP)

    Dr. Vicente Soriano

62. 
    The slowdown of new infections by human retroviruses has reached a plateau in Spain

    Article • Journal of Medical Virology, May 2023, Wiley

    Dr. Vicente Soriano

63. 
    Key Safety Issues in Treating People with Both Hepatitis C and HIV

    Article • Expert Opinion on Drug Safety, April 2023, Taylor & Francis

    Dr. Vicente Soriano, Octavio Corral Pazos de Provens

64. 
    Coinfection with Viral Hepatitis in HIV patients in 2023

    Article • Aids Reviews, March 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

65. 
    Viral hepatitis in persons living with HIV in the post-COVID era

    Article • Aids Reviews, March 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

66. 
    Genomic Determinants of Long COVID

    Article • February 2023, Research Square

    Dr. Vicente Soriano

67. 
    Susceptibility to hepatitis B virus infection in adults living in Spain

    Article • Liver International, February 2023, Wiley

    Dr. Vicente Soriano, Octavio Corral Pazos de Provens

68. 
    Envisioning hepatitis delta cure without functional hepatitis B cure

    Article • Aids Reviews, January 2023, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

69. 
    Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Dr. Vicente Soriano

70. 
    Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Article • Drug Design Development and Therapy, January 2023, Taylor & Francis

    Dr. Vicente Soriano

71. 
    Is SARS-CoV-2 the only cause of long-COVID?

    Article • Aids Reviews, December 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

72. 
    Controversy around SARS-CoV-2 Reinfections

    Article • Aids Reviews, December 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

73. 
    Alert for polio outbreaks in developed countries

    Article • Aids Reviews, November 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

74. 
    Impact of Potent Nucleos(t)ide Therapy on Hepatitis B Hospitalizations in Spain

    Article • Alimentary Pharmacology & Therapeutics, November 2022, Wiley

    Dr. Vicente Soriano, Octavio Corral Pazos de Provens

75. 
    A single-center comparison of our initial experiences in treating penile and urethral cancer with video-endoscopic inguinal lymphadenectomy (VEIL) and later experiences in melanoma cases

    Article • Frontiers in Surgery, September 2022, Frontiers

    Dr. Vicente Soriano

76. 
    Predictors of in-hospital mortality in HIV-infected patients with COVID-19

    Article • QJM, September 2022, Oxford University Press (OUP)

    Dr. Vicente Soriano

77. 
    Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies

    Article • International Journal of Infectious Diseases, September 2022, Elsevier

    Dr. Vicente Soriano

78. 
    Pre-Exposure Prophylaxis for viral infections other than HIV

    Article • Infezioni in Medicina, September 2022, Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche

    Dr. Vicente Soriano

79. 
    The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

    Article • Journal of Clinical Virology, August 2022, Elsevier

    Dr. Vicente Soriano

80. 
    International outbreak of monkeypox in men having sex with men

    Article • Aids Reviews, July 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

81. 
    Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Article • Future Microbiology, July 2022, Future Medicine

    Dr. Vicente Soriano

82. 
    Advances in Treating Hepatitis Delta and HIV Coinfection

    Article • Liver International, June 2022, Wiley

    Dr. Vicente Soriano, Octavio Corral Pazos de Provens

83. 
    Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Article • Journal of Viral Hepatitis, June 2022, Wiley

    Dr. Vicente Soriano

84. 
    A cure for HIV on the horizon

    Article • Aids Reviews, June 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

85. 
    News from CROI 2022 - caveats using antiretrovirals as HIV prophylaxis

    Article • Aids Reviews, June 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

86. 
    Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Article • Hepatology International, June 2022, Springer Science + Business Media

    Dr. Vicente Soriano

87. 
    Providing Spiritual Care to In-Hospital Patients During COVID-19: A Preliminary European Fact-Finding Study

    Article • Journal of Religion and Health, May 2022, Springer Science + Business Media

    Dr. Vicente Soriano

88. 
    Use of antibiotics in respiratory viral infections

    Article • Internal and Emergency Medicine, March 2022, Springer Science + Business Media

    Dr. Vicente Soriano

89. 
    A greater virulent HIV-1 subtype B variant has circulated in The Netherlands since the 1990’s

    Article • Aids Reviews, March 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

90. 
    Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

    Article • Aids Reviews, February 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

91. 
    Pilot study on the frequency of adverse effects on toenails in patients with breast cancer

    Article • International Journal of Dermatology, January 2022, Wiley

    Dr. Vicente Soriano

92. 
    Another patient has cured HIV infection

    Article • Aids Reviews, January 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

93. 
    The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control

    Article • Aids Reviews, January 2022, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

94. 
    Ultra-long-acting (XLA) antivirals for chronic viral hepatitis

    Article • International Journal of Infectious Diseases, January 2022, Elsevier

    Dr. Vicente Soriano

95. 
    Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

    Article • HIV Medicine, December 2021, Wiley

    Dr. Vicente Soriano

96. 
    Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain

    Article • International Journal of Infectious Diseases, November 2021, Elsevier

    Dr. Vicente Soriano

97. 
    Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

    Article • AIDS, October 2021, Wolters Kluwer Health

    Dr. Vicente Soriano

98. 
    New insights into the genetics of same-sex behavior

    Article • Aids Reviews, October 2021, Publicidad Permanyer, SLU

    Dr. Vicente Soriano

99. 
    Envisioning a hepatitis delta cure with new antivirals

    Article • Future Microbiology, September 2021, Future Medicine

    Dr. Vicente Soriano

100. 
     Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain

     Article • AIDS Research and Human Retroviruses, August 2021, Mary Ann Liebert Inc

     Dr. Vicente Soriano

101. 
     Hepatitis delta in patients hospitalized in Spain (1997–2018)

     Article • AIDS, July 2021, Wolters Kluwer Health

     Dr. Vicente Soriano

102. 
     COVID-19 in Madrid: Leading Pandemic Control after being the Spanish Epicenter

     Article • Aids Reviews, June 2021, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

103. 
     Consideraciones sobre la infección por HTLV-1 en España

     Article • Medicina Clínica, June 2021, Elsevier

     Dr. Vicente Soriano

104. 
     Third wave of COVID-19 in Madrid, Spain

     Article • International Journal of Infectious Diseases, June 2021, Elsevier

     Dr. Vicente Soriano

105. 
     The time to offer treatments for COVID-19

     Article • Expert Opinion on Investigational Drugs, April 2021, Taylor & Francis

     Dr. Vicente Soriano

106. 
     Main differences between the first and second waves of COVID-19 in Madrid, Spain

     Article • International Journal of Infectious Diseases, April 2021, Elsevier

     Dr. Vicente Soriano

107. 
     Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions

     Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

108. 
     COVID-19 Comes 40 Years After AIDS - Any Lesson?

     Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

109. 
     The Importance of Understanding the Stages of COVID-19 in Treatment and Trials

     Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

110. 
     New SARS-CoV-2 Variants Challenge Vaccines Protection

     Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

111. 
     Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation

     Article • Transplantation Proceedings, March 2021, Elsevier

     Dr. Vicente Soriano

112. 
     Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España

     Article • Medicina Clínica, March 2021, Elsevier

     Dr. Vicente Soriano

113. 
     Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis

     Article • Clinical Infectious Diseases, February 2021, Oxford University Press (OUP)

     Dr. Vicente Soriano

114. 
     Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

     Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), January 2021, SAGE Publications

     Dr. Vicente Soriano

115. 
     Unveiling Long COVID-19 Disease

     Article • Aids Reviews, December 2020, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

116. 
     A Key Action Plan for EDUCATION in a Global Crisis

     Article • December 2020, Springer Science + Business Media

     Dr. Vicente Soriano

117. 
     Acute Viral Hepatitis in Men Having Sex with Men

     Article • Aids Reviews, October 2020, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

118. 
     Coronavirus and other airborne agents with pandemic potential

     Article • Current Opinion in Environmental Science & Health, October 2020, Elsevier

     Dr. Vicente Soriano

119. 
     Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

     Article • International Journal of Infectious Diseases, August 2020, Elsevier

     Dr. Vicente Soriano

120. 
     Long-acting antiretroviral therapy

     Article • Nature Materials, July 2020, Springer Science + Business Media

     Dr. Vicente Soriano

121. 
     The Resurgence of Medical Ethics During the Coronavirus Disease (COVID)-19 Outbreak

     Article • Aids Reviews, July 2020, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

122. 
     Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections

     Article • Aids Reviews, July 2020, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

123. 
     Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain

     Article • Clinical Infectious Diseases, June 2020, Oxford University Press (OUP)

     Dr. Vicente Soriano

124. 
     THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19

     Article • June 2020, Cold Spring Harbor Laboratory Press

     Dr. Vicente Soriano

125. 
     Hospital admissions in individuals with HTLV-1 infection in Spain

     Article • AIDS, June 2020, Wolters Kluwer Health

     Dr. Vicente Soriano

126. 
     Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

     Article • Melanoma Research, June 2020, Wolters Kluwer Health

     Dr. Vicente Soriano

127. 
     Poetry in Response to the “Disengagement Plan”: Identity, Poetics and Politics

     Article • CLCWeb Comparative Literature and Culture, April 2020, Purdue University (bepress)

     Dr. Vicente Soriano

128. 
     HTLV-1 infection and health outcomes

     Article • The Lancet Infectious Diseases, April 2020, Elsevier

     Dr. Vicente Soriano

129. 
     HTLV-1 infection and health outcomes

     Article • The Lancet Infectious Diseases, April 2020, Elsevier

     Dr. Vicente Soriano

130. 
     Tough requirements for new antiretroviral drugs

     Article • The Lancet HIV, March 2020, Elsevier

     Dr. Vicente Soriano

131. 
     Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2

     Article • The Journal of Infectious Diseases, January 2020, Oxford University Press (OUP)

     Dr. Vicente Soriano

132. 
     Advances in hepatitis B therapeutics

     Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

     Dr. Vicente Soriano

133. 
     Keeping alive enterprises while embracing unprecedented COVID-19 restrictions

     Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

     Dr. Vicente Soriano

134. 
     Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains

     Article • Emerging Microbes & Infections, January 2020, Taylor & Francis

     Dr. Vicente Soriano

135. 
     Overt and occult hepatitis B among immigrants and native blood donors in Madrid, Spain

     Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

     Dr. Vicente Soriano

136. 
     Why such excess of mortality for COVID-19 in Spain?

     Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

     Dr. Vicente Soriano

137. 
     Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT...

     Article • Journal of Antimicrobial Chemotherapy, November 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

138. 
     Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

     Article • AIDS, November 2019, Wolters Kluwer Health

     Dr. Vicente Soriano

139. 
     HTLV testing of solid organ transplant donors

     Article • Clinical Transplantation, October 2019, Wiley

     Dr. Vicente Soriano

140. 
     HTLV-1 infection in solid organ transplant donors and recipients in Spain

     Article • BMC Infectious Diseases, August 2019, Springer Science + Business Media

     Dr. Vicente Soriano

141. 
     Update of the statements on biology and clinical impact of occult hepatitis B virus infection

     Article • Journal of Hepatology, August 2019, Elsevier

     Dr. Vicente Soriano

142. 
     A18 HIV-2 molecular epidemiology in Spain: 30 years since the first case

     Article • Virus Evolution, August 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

143. 
     Dusky erythema secondary to anti-MEK therapy

     Article • Melanoma Research, August 2019, Wolters Kluwer Health

     Dr. Vicente Soriano

144. 
     Jérôme Lejeune passed away 25 years ago

     Article • Hereditas, June 2019, Springer Science + Business Media

     Dr. Vicente Soriano

145. 
     HIV co-infection in HTLV-1 carriers in Spain

     Article • Virus Research, June 2019, Elsevier

     Dr. Vicente Soriano

146. 
     Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma

     Article • JAMA Dermatology, June 2019, American Medical Association (AMA)

     Dr. Vicente Soriano

147. 
     Hepatitis Delta Estimates in the United States Revisited

     Article • Clinical Infectious Diseases, April 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

148. 
     Occult hepatitis B and HIV infection

     Article • European Journal of Gastroenterology & Hepatology, April 2019, Wolters Kluwer Health

     Dr. Vicente Soriano

149. 
     Abstract P3-14-09: Hyperglycemia secondary to everolimus is associated with a prognosis improvement in hormone-sensitive metastatic breast cancer. A retrospective analysis

     Article • Cancer Research, February 2019, American Association for Cancer Research (AACR)

     Dr. Vicente Soriano

150. 
     Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

     Article • Journal of Antimicrobial Chemotherapy, February 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

151. 
     Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus

     Article • Open Forum Infectious Diseases, February 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

152. 
     Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

     Article • Open Forum Infectious Diseases, January 2019, Oxford University Press (OUP)

     Dr. Vicente Soriano

153. 
     Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS

     Article • Aids Reviews, January 2019, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

154. 
     Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana

     Article • Therapeutic Advances in Infectious Disease, January 2019, SAGE Publications

     Dr. Vicente Soriano

155. 
     Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals

     Article • Therapeutic Advances in Infectious Disease, January 2019, SAGE Publications

     Dr. Vicente Soriano

156. 
     Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2018, Wolters Kluwer Health

     Dr. Vicente Soriano

157. 
     Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain

     Article • European Journal of Gastroenterology & Hepatology, September 2018, Wolters Kluwer Health

     Dr. Vicente Soriano

158. 
     Short article

     Article • European Journal of Gastroenterology & Hepatology, September 2018, Wolters Kluwer Health

     Dr. Vicente Soriano

159. 
     Flash Smelting Copper Concentrates Spectral Emission Measurements

     Article • Sensors, June 2018, MDPI AG

     Dr. Vicente Soriano

160. 
     Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

     Article • Melanoma Research, June 2018, Wolters Kluwer Health

     Dr. Vicente Soriano

161. 
     AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities

     Article • Viruses, May 2018, MDPI AG

     Dr. Vicente Soriano

162. 
     Ipilimumab and radiation in patients with unresectable melanoma brain metastases: A multicenter, open label, phase-2, Spanish Melanoma Group (GEM) study (NCT-2013-001132-22).

     Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

     Dr. Vicente Soriano

163. 
     Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

     Article • Clinical Infectious Diseases, May 2018, Oxford University Press (OUP)

     Dr. Vicente Soriano

164. 
     Report from the International Conference on Viral Hepatitis (ICVH) – Chicago, October 2017

     Article • Aids Reviews, April 2018, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

165. 
     Treatment and prevention of HIV infection with long-acting antiretrovirals

     Article • Expert Review of Clinical Pharmacology, March 2018, Taylor & Francis

     Dr. Vicente Soriano

166. 
     Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges

     Article • Cancer, February 2018, Wiley

     Dr. Vicente Soriano

167. 
     Hepatitis Delta Enters a New Therapeutic Era

     Article • The Journal of Infectious Diseases, February 2018, Oxford University Press (OUP)

     Dr. Vicente Soriano

168. 
     Dabrafenib plus trametinib for compassionate use in metastatic melanoma

     Article • Medicine, December 2017, Wolters Kluwer Health

     Dr. Vicente Soriano

169. 
     Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

     Article • Open Forum Infectious Diseases, October 2017, Oxford University Press (OUP)

     Dr. Vicente Soriano

170. 
     Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure

     Article • Aids Reviews, October 2017, Publicidad Permanyer, SLU

     Dr. Vicente Soriano

171. 
     Human T-Lymphotropic Virus Infection in Hepatitis C Virus–Antibody Positive Patients in Spain

     Article • AIDS Research and Human Retroviruses, October 2017, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Enrique J. Calderon

172. 
     Need to Face Liver Cirrhosis after HCV Cure with Antivirals

     Article • EBioMedicine, October 2017, Elsevier

     Dr. Vicente Soriano

173. 
     Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

     Article • Annals of Translational Medicine, October 2017, AME Publishing Company

     Dr. Vicente Soriano

174. 
     Is Ribavirin Teratogenic in Humans? No Evidence So Far

     Article • Drug Safety, September 2017, Springer Science + Business Media

     Dr. Vicente Soriano

175. 
     Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

     Article • PLOS One, September 2017, PLOS

     Dr. Vicente Soriano

176. 
     Antiretroviral treatment of HIV-2 infection

     Article • Future Virology, August 2017, Future Medicine

     vicente soriano, Dr. Vicente Soriano

177. 
     Treatment of hepatitis C with new fixed dose combinations

     Article • Expert Opinion on Pharmacotherapy, July 2017, Taylor & Francis

     Dr. Vicente Soriano

178. 
     Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C

     Article • Expert Opinion on Drug Metabolism & Toxicology, July 2017, Taylor & Francis

     Dr. Vicente Soriano

179. 
     CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

     Article • Journal of Antimicrobial Chemotherapy, July 2017, Oxford University Press (OUP)

     Dr. Vicente Soriano

180. 
     Drug interactions in HIV-infected patients treated for hepatitis C

     Article • Expert Opinion on Drug Metabolism & Toxicology, July 2017, Taylor & Francis

     Dr. Vicente Soriano

181. 
     Dual antiretroviral therapy for HIV infection

     Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

     Dr. Vicente Soriano

182. 
     Human T-lymphotropic virus type 1 infection and disease in Spain

     Article • AIDS, July 2017, Wolters Kluwer Health

     Dr. Vicente Soriano, Enrique J. Calderon

183. 
     HIV type 2 epidemic in Spain

     Article • AIDS, June 2017, Wolters Kluwer Health

     Dr. Vicente Soriano

184. 
     New antivirals for the treatment of chronic hepatitis B

     Article • Expert Opinion on Investigational Drugs, May 2017, Taylor & Francis

     Dr. Vicente Soriano

185. 
     Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation

     Article • Annals of Pharmacotherapy, May 2017, SAGE Publications

     Dr. Vicente Soriano

186. 
     Hepatitis delta and HIV infection

     Article • AIDS, April 2017, Wolters Kluwer Health

     Dr. Vicente Soriano

187. 
     Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

     Article • Journal of Antimicrobial Chemotherapy, March 2017, Oxford University Press (OUP)

     Dr. Vicente Soriano, Enrique J. Calderon

188. 
     A loud tear — acute aortic regurgitation with an unusual presentation

     Article • Kardiologia Polska, February 2017, Polskie Towarzystwo Kardiologiczne

     Dr. Vicente Soriano

189. 
     Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease

     Article • Journal of Cerebral Blood Flow & Metabolism, January 2017, SAGE Publications

     Dr Pablo A Evelson, Dr. Vicente Soriano

190. 
     Decline and changing profile of hepatitis delta among injection drug users in Spain

     Article • Antiviral Therapy, January 2017, International Medical Press

     Dr. Vicente Soriano

191. 
     Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

     Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

     Dr. Vicente Soriano

192. 
     Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C

     Article • Antiviral Therapy, January 2017, International Medical Press

     Dr. Vicente Soriano

193. 
     The global spread of HIV-1 subtype B epidemic

     Article • Infection Genetics and Evolution, December 2016, Elsevier

     Dr. Vicente Soriano

194. 
     Coronary angiography after successful thrombolysis — Is the recommended time interval of 24 h an important issue?

     Article • International Journal of Cardiology, November 2016, Elsevier

     Dr. Vicente Soriano

195. 
     Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

     Article • Journal of Translational Medicine, September 2016, Springer Science + Business Media

     Dr Isidoro Martinez, Dr. Vicente Soriano

196. 
     Short article

     Article • European Journal of Gastroenterology & Hepatology, August 2016, Wolters Kluwer Health

     Dr. Vicente Soriano

197. 
     Hepatitis C virus resistance to the new direct-acting antivirals

     Article • Expert Opinion on Drug Metabolism & Toxicology, July 2016, Taylor & Francis

     Dr. Vicente Soriano

198. 
     Can evolutionary constraints explain the rarity of nitrogen‐fixing trees in high‐latitude forests?

     Article • New Phytologist, July 2016, Wiley

     Dr. Vicente Soriano

199. 
     Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

     Article • JAMA, July 2016, American Medical Association (AMA)

     Dr. Vicente Soriano

200. 
     Is HIV still a special population for the treatment of hepatitis C?

     Article • AIDS, July 2016, Wolters Kluwer Health

     Dr. Vicente Soriano

201. 
     A machine vision system for automatic detection of parasites Edotea magellanica in shell-off cooked clam Mulinia edulis

     Article • Journal of Food Engineering, July 2016, Elsevier

     Dr. Vicente Soriano

202. 
     SOLAR-2: the sun also rises for cirrhotics

     Article • The Lancet Infectious Diseases, June 2016, Elsevier

     Dr. Vicente Soriano

203. 
     Treatment patterns of adjuvant interferon-α2b for high-risk melanoma

     Article • Melanoma Research, June 2016, Wolters Kluwer Health

     Dr. Vicente Soriano

204. 
     MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression

     Article • PLOS One, May 2016, PLOS

     Dr. Vicente Soriano, Dr Agustin Valenzuela-Fernandez

205. 
     Prevention and management of treatment failure to new oral hepatitis C drugs

     Article • Expert Opinion on Pharmacotherapy, May 2016, Taylor & Francis

     Dr. Vicente Soriano

206. 
     Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013

     Article • Journal of Infection, May 2016, Elsevier

     Dr. Vicente Soriano

207. 
     Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience

     Article • Revista de Oncología, March 2016, Springer Science + Business Media

     Dr. Vicente Soriano

208. 
     IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

     Article • Liver International, March 2016, Wiley

     Dr. Vicente Soriano

209. 
     Delta hepatitis: new approaches to therapy

     Article • Future Virology, March 2016, Future Medicine

     Dr. Vicente Soriano

210. 
     Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy

     Article • AIDS Research and Human Retroviruses, March 2016, Mary Ann Liebert Inc

     Dr. Vicente Soriano

211. 
     Infection-related and -unrelated malignancies, HIV and the aging population

     Article • HIV Medicine, February 2016, Wiley

     Dr. Vicente Soriano

212. 
     Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

     Article • Antiviral Therapy, January 2016, International Medical Press

     Dr. Vicente Soriano

213. 
     High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy

     Article • Antiviral Therapy, January 2016, International Medical Press

     Dr. Vicente Soriano

214. 
     HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)

     Article • Revista do Instituto de Medicina Tropical de São Paulo, January 2016, FapUNIFESP (SciELO)

     Dr. Vicente Soriano

215. 
     Rapid Changes in Cholesterol in Chronic Hepatitis C Patients Treated with Antivirals and Potential Impacton Cardiovascular Risk

     Article • Journal of Hepatology, January 2016, Elsevier

     Dr. Vicente Soriano

216. 
     Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

     Article • Journal of Antimicrobial Chemotherapy, December 2015, Oxford University Press (OUP)

     Professor Peter Sasieni, Dr. Vicente Soriano

217. 
     ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection

     Article • PLOS One, December 2015, PLOS

     Dr. Vicente Soriano

218. 
     Epigenetic regulation of puberty via Zinc finger protein-mediated transcriptional repression

     Article • Nature Communications, December 2015, Springer Science + Business Media

     Dr. Vicente Soriano

219. 
     Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease

     Article • Inflammatory Bowel Diseases, December 2015, Oxford University Press (OUP)

     Dr. Vicente Soriano

220. 
     Linfoma primário do coração em doente com neoplasia renal síncrona

     Article • Revista Portuguesa de Cardiologia, December 2015, Elsevier

     Dr. Vicente Soriano

221. 
     Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

     Article • HIV Medicine, November 2015, Wiley

     Dr. Vicente Soriano, Professor Peter Sasieni

222. 
     Hypoglycemia in a diabetic patient during hepatitis C therapy

     Article • Hepatology, November 2015, Wiley

     Dr. Vicente Soriano

223. 
     New hepatitis C therapies for special patient populations

     Article • Expert Opinion on Pharmacotherapy, November 2015, Informa Healthcare

     Dr. Vicente Soriano

224. 
     Corrigendum

     Article • HIV Clinical Trials, November 2015, Taylor & Francis

     Dr. Vicente Soriano

225. 
     Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

     Article • The Lancet HIV, November 2015, Elsevier

     Dr. Vicente Soriano

226. 
     Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

     Article • Clinical Microbiology and Infection, November 2015, Elsevier

     Dr. Vicente Soriano

227. 
     Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

     Article • PLOS One, October 2015, PLOS

     Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Dr Graham A Williams

228. 
     Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C

     Article • Journal of Clinical Virology, October 2015, Elsevier

     Dr. Vicente Soriano

229. 
     Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

     Article • Hepatology, October 2015, Wiley

     Dr. Vicente Soriano

230. 
     Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

     Article • Journal of Viral Hepatitis, September 2015, Wiley

     Dr. Vicente Soriano

231. 
     IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection

     Article • AIDS, September 2015, Wolters Kluwer Health

     Dr. Vicente Soriano

232. 
     Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients

     Article • Current Opinion in HIV and AIDS, September 2015, Wolters Kluwer Health

     Dr. Vicente Soriano

233. 
     Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma

     Article • European Journal of Cancer, September 2015, Elsevier

     Dr. Vicente Soriano

234. 
     Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

     Article • The Lancet HIV, August 2015, Elsevier

     Dr. Vicente Soriano

235. 
     Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

     Article • HIV Medicine, July 2015, Wiley

     Dr. Vicente Soriano, Prof Robert Colebunders

236. 
     Tenofovir for Hepatitis Delta

     Article • Hepatology, July 2015, Wiley

     Dr. Vicente Soriano

237. 
     Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects

     Article • Expert Opinion on Drug Safety, July 2015, Informa Healthcare

     Dr. Vicente Soriano

238. 
     Emerging Challenges in Managing Hepatitis B in HIV Patients

     Article • Current HIV/AIDS Reports, July 2015, Springer Science + Business Media

     Dr. Vicente Soriano

239. 
     Clinical Translation of Nanomedicine

     Article • Chemical Reviews, June 2015, American Chemical Society (ACS)

     Dr. Vicente Soriano

240. 
     Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner

     Article • Liver International, June 2015, Wiley

     Dr. Vicente Soriano

241. 
     From respiratory sensitization to food allergy: Anaphylactic reaction after ingestion of mushrooms (Agaricus bisporus)

     Article • Medical Mycology Case Reports, June 2015, Elsevier

     Dr. Vicente Soriano

242. 
     Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

     Article • PLoS Medicine, June 2015, PLOS

     Dr. Vicente Soriano

243. 
     Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

     Article • HIV Medicine, May 2015, Wiley

     Dr. Vicente Soriano

244. 
     Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

     Article • Liver International, April 2015, Wiley

     Dr. Vicente Soriano

245. 
     High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes

     Article • Journal of Epidemiology & Community Health, April 2015, BMJ

     Dr. Vicente Soriano

246. 
     High nevus counts confer a favorable prognosis in melanoma patients

     Article • International Journal of Cancer, April 2015, Wiley

     Dr. Vicente Soriano

247. 
     Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

     Article • PLoS Medicine, April 2015, PLOS

     Dr. Vicente Soriano

248. 
     Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2015, Wolters Kluwer Health

     Dr. Vicente Soriano, Prof Robert Colebunders

249. 
     Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

     Article • HIV Clinical Trials, April 2015, Taylor & Francis

     Dr. Vicente Soriano

250. 
     TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

     Article • Journal of Clinical Virology, April 2015, Elsevier

     Dr. Vicente Soriano

251. 
     P0838 : Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies

     Article • Journal of Hepatology, April 2015, Elsevier

     Dr. Vicente Soriano

252. 
     Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

     Article • PLoS Medicine, March 2015, PLOS

     Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Lut Lynen, Hugh Montgomery, Prof Robert Colebunders

253. 
     Dolutegravir for the treatment of HIV-2 infection

     Article • Journal of Clinical Virology, March 2015, Elsevier

     Dr. Vicente Soriano

254. 
     Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs

     Article • Virology Journal, January 2015, Springer Science + Business Media

     Dr. Vicente Soriano

255. 
     Gastrointestinal: Botulinum toxin effective in refractory gastroparesis in paediatric practice

     Article • Journal of Gastroenterology and Hepatology, January 2015, Wiley

     Dr. Vicente Soriano

256. 
     Agonist-Dependent Modulation of Cell Surface Expression of the Cold Receptor TRPM8

     Article • Journal of Neuroscience, January 2015, Society for Neuroscience

     Professor Katharina Zimmermann, Dr. Vicente Soriano

257. 
     Boosted Lopinavir– Versus Boosted Atazanavir–Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries

     Article • Clinical Infectious Diseases, January 2015, Oxford University Press (OUP)

     Dr. Vicente Soriano

258. 
     Drug interactions with new hepatitis C oral drugs

     Article • Expert Opinion on Drug Metabolism & Toxicology, January 2015, Informa Healthcare

     Dr. Vicente Soriano

259. 
     Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis

     Article • Antiviral Therapy, January 2015, International Medical Press

     Dr. Vicente Soriano

260. 
     Hepatitis C cure with antiviral therapy – benefits beyond the liver

     Article • Antiviral Therapy, January 2015, International Medical Press

     Dr. Vicente Soriano

261. 
     Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1–Infected Patients Treated With Combined Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2015, Wolters Kluwer Health

     Dr. Vicente Soriano

262. 
     STARTVerso4

     Article • AIDS, January 2015, Wolters Kluwer Health

     Dr. Vicente Soriano

263. 
     Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

     Article • Clinical Microbiology and Infection, January 2015, Elsevier

     Dr. Vicente Soriano

264. 
     Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007–2012)

     Article • Clinical Microbiology and Infection, January 2015, Elsevier

     Dr. Vicente Soriano

265. 
     Integrase Inhibitors

     Article • January 2015, Springer Science + Business Media

     Dr. Vicente Soriano

266. 
     Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions

     Article • PLOS One, December 2014, PLOS

     Dr. Vicente Soriano

267. 
     Advances in treating drug-resistant hepatitis B virus in HIV-infected patients

     Article • Expert Opinion on Pharmacotherapy, December 2014, Informa Healthcare

     Dr. Vicente Soriano

268. 
     Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis

     Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

     Dr. Vicente Soriano

269. 
     Ipilimumab for advanced melanoma

     Article • Melanoma Research, December 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

270. 
     Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

     Article • AIDS, November 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

271. 
     Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

     Article • The Lancet, November 2014, Elsevier

     Dr. Vicente Soriano

272. 
     Redefining the HIV epidemic in Nigeria

     Article • AIDS, November 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

273. 
     Gene therapy for HIV infection

     Article • Expert Opinion on Biological Therapy, October 2014, Informa Healthcare

     Dr. Vicente Soriano

274. 
     Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

     Article • Liver International, October 2014, Wiley

     Dr Stuart C. Ray, Dr. Vicente Soriano

275. 
     Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients

     Article • AIDS, October 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

276. 
     PPARγ2 Pro12Ala Polymorphism Is Associated With Sustained Virological Response in HIV/HCV-Coinfected Patients Under HCV Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

277. 
     Molecular Epidemiology and Clinical Features of Human T Cell Lymphotropic Virus Type 1 Infection in Spain

     Article • AIDS Research and Human Retroviruses, September 2014, Mary Ann Liebert Inc

     Dr. Vicente Soriano

278. 
     Braf Mutation Analysis in Cell Free Tumoral Dna (Cfdna) of Melanoma Patients: Preliminary Results from the Spanish Melanoma Group Prospective Study Gem1304

     Article • Annals of Oncology, September 2014, Elsevier

     Dr. Vicente Soriano

279. 
     Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies

     Article • PLOS One, July 2014, PLOS

     Dr. Vicente Soriano

280. 
     Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

     Article • The Lancet, July 2014, Elsevier

     Dr. Vicente Soriano, Prof Robert Colebunders

281. 
     Hepatitis E: una enfermedad viral emergente

     Article • Medicina Clínica, July 2014, Elsevier

     Dr. Vicente Soriano

282. 
     X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

     Article • AIDS, July 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

283. 
     Pharmacogenetics of antiretroviral therapy

     Article • Expert Opinion on Drug Metabolism & Toxicology, June 2014, Informa Healthcare

     Dr. Vicente Soriano

284. 
     A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

     Article • Infection, June 2014, Springer Science + Business Media

     Dr. Vicente Soriano, Prof Robert Colebunders

285. 
     Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy

     Article • AIDS, June 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

286. 
     Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes

     Article • The International Journal of Tuberculosis and Lung Disease, June 2014, International Union Against Tuberculosis and Lung Disease

     Dr. Vicente Soriano

287. 
     Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

     Article • HIV Medicine, May 2014, Wiley

     Dr. Vicente Soriano, Prof Robert Colebunders

288. 
     High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

     Article • HIV Medicine, May 2014, Wiley

     Dr. Vicente Soriano

289. 
     Treatment of hepatitis C in HIV patients in the new DAA era

     Article • BMC Infectious Diseases, May 2014, Springer Science + Business Media

     Dr. Vicente Soriano

290. 
     Towards hepatitis C eradication from the HIV-infected population

     Article • Antiviral Research, May 2014, Elsevier

     Dr. Vicente Soriano

291. 
     HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

     Article • Journal of Antimicrobial Chemotherapy, April 2014, Oxford University Press (OUP)

     Enrique J. Calderon, Dr. Vicente Soriano

292. 
     Dolutegravir, abacavir and lamivudine as HIV therapy

     Article • Expert Opinion on Pharmacotherapy, April 2014, Informa Healthcare

     Dr. Vicente Soriano

293. 
     IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians

     Article • PLOS One, April 2014, PLOS

     Dr. Vicente Soriano

294. 
     Management and treatment of chronic hepatitis B in HIV-positive patients

     Article • Annals of Medicine, April 2014, Taylor & Francis

     Dr. Vicente Soriano

295. 
     Infecciones por el virus de la inmunodeficiencia humana tipo 2 y por los virus linfotrópicos de células T humanas en España

     Article • Medicina Clínica, April 2014, Elsevier

     Dr. Vicente Soriano

296. 
     Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy

     Article • Journal of Infection, April 2014, Elsevier

     Dr. Vicente Soriano

297. 
     P751 DISTINCT VALUES OF LIVER STIFFNESS PREDICT PROGRESSION TO ADVANCED LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

298. 
     P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

299. 
     P755 HEPATITIS C COINFECTION INDEPENDENTLY INCREASES CARDIOVASCULAR RISK IN HIV-INFECTED PATIENTS

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

300. 
     P1133 COMPARISON OF 24 AND 48 WEEKS OF TREATMENT WITH FALDAPREVIR AND PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH DETECTABLE BUT NOT QUANTIFIABLE HCV RNA AT WEEK 4

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

301. 
     P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

302. 
     P750 SPONTANEOUS HCV CLEARANCE IN HIV PATIENTS WITH CHRONIC HEPATITIS C BEARING FAVORABLE IL28B ALLELES ON ANTIRETROVIRAL THERAPY

     Article • Journal of Hepatology, April 2014, Elsevier

     Dr. Vicente Soriano

303. 
     Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

     Article • BMC Nephrology, March 2014, Springer Science + Business Media

     Dr. Vicente Soriano, Prof Robert Colebunders

304. 
     Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations

     Article • PLOS One, March 2014, PLOS

     Dr. Vicente Soriano

305. 
     Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

     Article • Clinical Infectious Diseases, March 2014, Oxford University Press (OUP)

     Dr. Vicente Soriano

306. 
     Deteriorating renal function and clinical outcomes in HIV-positive persons

     Article • AIDS, March 2014, Wolters Kluwer Health

     Dr. Vicente Soriano, Prof Robert Colebunders

307. 
     European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients

     Article • HIV Medicine, February 2014, Wiley

     Dr. Vicente Soriano

308. 
     Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons

     Article • The Journal of Infectious Diseases, February 2014, Oxford University Press (OUP)

     Dr. Vicente Soriano

309. 
     Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

     Article • Virology, February 2014, Elsevier

     Dr. Vicente Soriano

310. 
     Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

     Article • AIDS, February 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

311. 
     Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction

     Article • Open Heart, February 2014, BMJ

     Dr. Vicente Soriano

312. 
     Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe

     Article • PLOS One, January 2014, PLOS

     Dr. Vicente Soriano, Prof Robert Colebunders

313. 
     Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies

     Article • Antiviral Therapy, January 2014, International Medical Press

     Dr. Vicente Soriano

314. 
     Liver fibrosis progression despite HCV cure with antiviral therapy in HIV–HCV-coinfected patients

     Article • Antiviral Therapy, January 2014, International Medical Press

     Dr. Vicente Soriano

315. 
     Long-term survival and liver-related events after peginterferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

     Article • Antiviral Therapy, January 2014, International Medical Press

     Dr. Vicente Soriano

316. 
     Very late HCV relapse following triple therapy for hepatitis C

     Article • Antiviral Therapy, January 2014, International Medical Press

     Dr. Vicente Soriano

317. 
     ACSM4 Polymorphisms Are Associated With Rapid AIDS Progression in HIV-Infected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2014, Wolters Kluwer Health

     Dr. Vicente Soriano

318. 
     A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice

     Article • Nature Communications, December 2013, Springer Science + Business Media

     Dr. Vicente Soriano

319. 
     Emerging antiretroviral drugs

     Article • Expert Opinion on Pharmacotherapy, November 2013, Informa Healthcare

     Dr. Vicente Soriano

320. 
     Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

     Article • HIV Medicine, November 2013, Wiley

     Dr Victor Asensi, Dr. Vicente Soriano

321. 
     Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

322. 
     Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

     Article • AIDS, November 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

323. 
     Associations between immune depression and cardiovascular events in HIV infection

     Article • AIDS, November 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

324. 
     Strategic use of lamivudine in the management of chronic hepatitis B

     Article • Antiviral Research, November 2013, Elsevier

     Dr. Vicente Soriano

325. 
     A polymorphism linked to RRAS ,SCAF1 ,IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers

     Article • Liver International, October 2013, Wiley

     Dr. Vicente Soriano

326. 
     Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study

     Article • BMC Infectious Diseases, October 2013, Springer Science + Business Media

     Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano

327. 
     Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

     Article • Journal of Viral Hepatitis, October 2013, Wiley

     Dr. Vicente Soriano

328. 
     Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

     Article • Journal of Clinical Virology, October 2013, Elsevier

     Dr. Vicente Soriano

329. 
     Epidemiology of viral hepatitis

     Article • Hepatology, October 2013, Wiley

     Dr. Vicente Soriano

330. 
     Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort

     Article • HIV Medicine, September 2013, Wiley

     Dr. Vicente Soriano

331. 
     Treating hepatitis C in injection drug users

     Article • Nature Reviews Gastroenterology & Hepatology, September 2013, Springer Science + Business Media

     Dr. Vicente Soriano

332. 
     Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

     Article • AIDS, September 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

333. 
     Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals

     Article • Current Hepatology Reports, August 2013, Springer Science + Business Media

     Dr. Vicente Soriano

334. 
     Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

     Article • British Journal of Cancer, August 2013, Springer Science + Business Media

     Dr. Vicente Soriano

335. 
     All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010

     Article • BMC Infectious Diseases, August 2013, Springer Science + Business Media

     Dr. Vicente Soriano

336. 
     Faldaprevir and Deleobuvir for HCV Genotype 1 Infection

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

337. 
     Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

     Article • Journal of Hepatology, August 2013, Elsevier

     Dr. Vicente Soriano

338. 
     Recortes sanitarios e infección por el virus de la inmunodeficiencia humana

     Article • Medicina Clínica, August 2013, Elsevier

     Dr. Vicente Soriano

339. 
     Hepatitis B in HIV-Infected Patients

     Article • Clinics in Liver Disease, August 2013, Elsevier

     Dr. Vicente Soriano

340. 
     Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

     Article • HIV Medicine, July 2013, Wiley

     Dr. Vicente Soriano

341. 
     Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves

     Article • Journal of Medical Virology, July 2013, Wiley

     Dr. Vicente Soriano

342. 
     Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1

     Article • Deutsche Zeitschrift für Nervenheilkunde, July 2013, Springer Science + Business Media

     Dr. Vicente Soriano

343. 
     Update on HIV/HCV Coinfection

     Article • Current HIV/AIDS Reports, July 2013, Springer Science + Business Media

     Dr. Vicente Soriano

344. 
     Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia

     Article • Journal of Antimicrobial Chemotherapy, July 2013, Oxford University Press (OUP)

     Dr. Vicente Soriano

345. 
     Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response

     Article • Journal of Infection, July 2013, Elsevier

     Dr. Vicente Soriano

346. 
     Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

     Article • AIDS, July 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

347. 
     Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management

     Article • Expert Opinion on Drug Safety, June 2013, Informa Healthcare

     Dr. Vicente Soriano

348. 
     Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

     Article • Liver International, June 2013, Wiley

     Dr. Vicente Soriano

349. 
     HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

     Article • AIDS, June 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

350. 
     Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection

     Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2013, Springer Science + Business Media

     Dr. Vicente Soriano

351. 
     Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

     Article • PLOS One, May 2013, PLOS

     Dr. Vicente Soriano

352. 
     Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

     Article • Annals of Internal Medicine, May 2013, American College of Physicians

     Dr. Vicente Soriano

353. 
     Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus

     Article • Journal of Virology, May 2013, ASM Journals

     Professor Elodie Ghedin, Dr. Vicente Soriano

354. 
     Unusual manifestations of a common gastrointestinal disorder

     Article • Journal of Paediatrics and Child Health, May 2013, Wiley

     Dr. Vicente Soriano

355. 
     HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

     Article • AIDS, May 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

356. 
     Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

     Article • Journal of Antimicrobial Chemotherapy, April 2013, Oxford University Press (OUP)

     Dr. Vicente Soriano

357. 
     Hepatitis C therapy with HCV NS5B polymerase inhibitors

     Article • Expert Opinion on Pharmacotherapy, April 2013, Informa Healthcare

     Dr. Vicente Soriano

358. 
     Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin

     Article • Clinical Infectious Diseases, April 2013, Oxford University Press (OUP)

     Dr. Vicente Soriano

359. 
     Hepatitis B, C, and D and HIV Infections among Immigrants from Equatorial Guinea Living in Spain

     Article • American Journal of Tropical Medicine and Hygiene, April 2013, American Society of Tropical Medicine and Hygiene

     Dr. Vicente Soriano

360. 
     Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy

     Article • AIDS, April 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

361. 
     Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV–hepatitis C virus coinfected patients

     Article • AIDS, April 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

362. 
     985 INCREASING RATES OF ACUTE HEPATITIS C ALONG WITH HIGH RATES OF SYPHILIS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN IN MADRID

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

363. 
     1227 AN ANALYSIS OF RESPONSE RATES BY FIBROSIS STAGE IN PATIENTS TREATED WITH FALDAPREVIR, BI 207127 AND RIBAVIRIN IN THE SOUND-C2 STUDY

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

364. 
     496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPY

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

365. 
     882 GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

366. 
     1186 ITPA GENE VARIANTS PREDICT HEMOLYTIC RIBAVIRIN INDUCED ANAEMIA IN PATIENTS TREATED WITH THE INTERFERON-FREE REGIMEN OF FALDAPREVIR, BI 207127 AND RIBAVIRIN IN SOUND-C2

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

367. 
     883 PREDICTION OF RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN BY INTERLEUKIN 28B GENOTYPE IS MODIFIED BY SNPS AT MULTIPLE GENES IN HIV/HEPATITIS C VIRUS GENOTYPE 1/4-COINFECTED PATIENTS

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

368. 
     1220 TRIPLE COMBINATION THERAPY FOR HEPATITIS C WITH TELAPREVIR EXHIBITS GREATER EARLY ANTIVIRAL SUPPRESSION THAN WITH BOCEPREVIR REGARDLESS HIV STATUS

     Article • Journal of Hepatology, April 2013, Elsevier

     Dr. Vicente Soriano

369. 
     Resistance to antiretroviral drugs

     Article • April 2013, Future Medicine

     Dr. Vicente Soriano

370. 
     Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

     Article • HIV Medicine, March 2013, Wiley

     Dr. Vicente Soriano

371. 
     Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid   (A ) Peptide Catabolism and Functionality

     Article • Journal of Biological Chemistry, March 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Pablo A Evelson, Dr. Vicente Soriano

372. 
     Contraindication of ART following a sperm FISH analysis, even though only 12% of the spermatozoa had enlarged heads

     Article • Systems Biology in Reproductive Medicine, March 2013, Taylor & Francis

     Dr. Vicente Soriano

373. 
     Sensitive Cell-Based Assay for Determination of Human Immunodeficiency Virus Type 1 Coreceptor Tropism

     Article • Journal of Clinical Microbiology, March 2013, ASM Journals

     Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Dr. Vicente Soriano

374. 
     Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

     Article • The Lancet, March 2013, Elsevier

     Dr. Vicente Soriano

375. 
     Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

     Article • AIDS, March 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

376. 
     The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies

     Article • PLOS One, February 2013, PLOS

     Dr. Vicente Soriano

377. 
     Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya

     Article • The Journal of Infectious Diseases, February 2013, Oxford University Press (OUP)

     Dr. Vicente Soriano

378. 
     Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

     Article • Clinical Infectious Diseases, January 2013, Oxford University Press (OUP)

     Dr. Vicente Soriano

379. 
     Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients

     Article • AIDS, January 2013, Wolters Kluwer Health

     Dr Mar Masiá, Dr. Vicente Soriano

380. 
     Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

     Article • AIDS, January 2013, Wolters Kluwer Health

     Dr Josep M Llibre, Dr. Vicente Soriano

381. 
     Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

     Article • AIDS, January 2013, Wolters Kluwer Health

     Dr. Vicente Soriano

382. 
     Liver fibrosis progression in HIV–HCV-coinfected patients treated with distinct antiretroviral drugs and impact of peginterferon-ribavirin therapy

     Article • Antiviral Therapy, January 2013, International Medical Press

     Dr. Vicente Soriano

383. 
     Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

     Article • Antiviral Therapy, January 2013, International Medical Press

     Dr. Vicente Soriano

384. 
     The changing face of hepatitis C in the new era of direct-acting antivirals

     Article • Antiviral Research, January 2013, Elsevier

     Dr. Vicente Soriano

385. 
     Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

     Article • Antiviral Therapy, January 2013, International Medical Press

     Dr. Vicente Soriano

386. 
     Insulysin

     Article • January 2013, Elsevier

     Dr. Vicente Soriano

387. 
     Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

     Article • Frontiers in Cellular Neuroscience, January 2013, Frontiers

     Dr. Vicente Soriano

388. 
     Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library

     Article • European Journal of Immunology, December 2012, Wiley

     Dr. Vicente Soriano

389. 
     IL28RApolymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

     Article • Journal of Viral Hepatitis, December 2012, Wiley

     Dr. Vicente Soriano

390. 
     A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

     Article • Journal of Antimicrobial Chemotherapy, December 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

391. 
     Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

     Article • The Journal of Infectious Diseases, December 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

392. 
     Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

     Article • Infectious Disease Clinics of North America, December 2012, Elsevier

     Dr. Vicente Soriano

393. 
     HIV gag-specific immune response mediated by double negative (CD3+CD4−CD8−) T cells in HIV-exposed seronegative individuals

     Article • Journal of Medical Virology, November 2012, Wiley

     Dr. Vicente Soriano

394. 
     Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain

     Article • HIV Medicine, November 2012, Wiley

     Dr. Vicente Soriano

395. 
     Increases in acute hepatitis C (HCV) incidence across Europe: which regions and patient groups are affected?

     Article • Journal of the International AIDS Society, November 2012, Wiley

     Dr. Vicente Soriano

396. 
     Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

     Article • Journal of the International AIDS Society, November 2012, Wiley

     Dr. Vicente Soriano

397. 
     Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics

     Article • International Journal of Epidemiology, November 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

398. 
     Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class

     Article • Clinical Microbiology and Infection, November 2012, Elsevier

     Dr. Vicente Soriano

399. 
     KIT Mutations in a Series of Melanomas and Their Impact on Treatment With Imatinib

     Article • Actas Dermo-Sifiliográficas (English Edition), November 2012, Elsevier

     Dr. Vicente Soriano

400. 
     Pharmacokinetics of new oral hepatitis C antiviral drugs

     Article • Expert Opinion on Drug Metabolism & Toxicology, October 2012, Informa Healthcare

     Dr. Vicente Soriano

401. 
     Hepatitis C Therapy: Highlights From the 2012 Annual Meeting of the European Association for the Study of the Liver

     Article • Clinical Infectious Diseases, October 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

402. 
     Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

     Article • Journal of the International AIDS Society, October 2012, Wiley

     Dr. Vicente Soriano

403. 
     Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

     Article • Retrovirology, October 2012, Springer Science + Business Media

     Dr Dimitrios Paraskevis, Dr. Vicente Soriano

404. 
     The inaccuracy of surface-measured model-derived tibiofemoral kinematics

     Article • Journal of Biomechanics, October 2012, Elsevier

     Professor Scott Tashman, Dr. Vicente Soriano

405. 
     Short Communication: Does Interleukin-28B Single Nucleotide Polymorphisms Influence the Natural History of Hepatitis B?

     Article • AIDS Research and Human Retroviruses, October 2012, Mary Ann Liebert Inc

     Dr. Vicente Soriano

406. 
     Short Communication: RNASEL Alleles and Susceptibility to Infection by Human Retroviruses and Hepatitis Viruses

     Article • AIDS Research and Human Retroviruses, October 2012, Mary Ann Liebert Inc

     Dr. Vicente Soriano

407. 
     Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms

     Article • AIDS, September 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

408. 
     Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

     Article • Journal of Clinical Virology, September 2012, Elsevier

     Dr. Vicente Soriano

409. 
     Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

     Article • AIDS, September 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

410. 
     Prevalence of Xenotropic Murine Leukemia Virus-Related Virus Infection in Different Risk Populations in Spain

     Article • AIDS Research and Human Retroviruses, September 2012, Mary Ann Liebert Inc

     Dr. Vicente Soriano

411. 
     The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study

     Article • AIDS, August 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

412. 
     Cardiovascular Disease Risk in HIV Infection and Endothelial Progenitor Cells

     Article • The Journal of Infectious Diseases, August 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

413. 
     Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

     Article • Retrovirology, August 2012, Springer Science + Business Media

     Dr. Vicente Soriano, Dr Patricia P Rodríguez-Inés

414. 
     Management of hepatitis C in HIV and/or HBV co-infected patients

     Article • Best Practice & Research Clinical Gastroenterology, August 2012, Elsevier

     Dr. Vicente Soriano

415. 
     No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

     Article • Antiviral Research, August 2012, Elsevier

     Dr. Vicente Soriano

416. 
     Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study

     Article • PLOS One, July 2012, PLOS

     Dr. Vicente Soriano

417. 
     Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-  for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial

     Article • The Journal of Infectious Diseases, July 2012, Oxford University Press (OUP)

     Dr Victor Asensi, Dr. Vicente Soriano

418. 
     Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells

     Article • AIDS Research and Human Retroviruses, July 2012, Mary Ann Liebert Inc

     Dr. Vicente Soriano

419. 
     Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up

     Article • AIDS, July 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

420. 
     Cardiac Apical Aneurysm secondary to ibuprofen-induced type 1-Kounis Syndrome

     Article • International Journal of Cardiology, July 2012, Elsevier

     Dr. Vicente Soriano

421. 
     Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms

     Article • European Journal of Preventive Cardiology, June 2012, SAGE Publications

     Dr. Vicente Soriano

422. 
     Differences in Virological Response to Peginterferon-α Plus Ribavirin in HIV-Positive Patients Coinfected With HCV Subtypes 1a or 1b

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

423. 
     Definition of Advanced Age in HIV-Infection: Looking for an Age Cut-Off.

     Article • AIDS Research and Human Retroviruses, May 2012, Mary Ann Liebert Inc

     Dr Victor Asensi, Dr. Vicente Soriano

424. 
     Author's response: expert reviews: who are they for?

     Article • Expert Opinion on Pharmacotherapy, May 2012, Informa Healthcare

     Dr. Vicente Soriano

425. 
     A New Era for Hepatitis C—New Diagnostics Tools and New Weapons

     Article • ACS Medicinal Chemistry Letters, May 2012, American Chemical Society (ACS)

     Dr. Vicente Soriano

426. 
     HIV and Liver Disease

     Article • Seminars in Liver Disease, May 2012, Thieme Publishing Group

     Dr. Vicente Soriano

427. 
     Infección por el VIH-2, virus linfotrópico de células T y nuevos retrovirus humanos en España

     Article • Medicina Clínica, May 2012, Elsevier

     Dr. Vicente Soriano

428. 
     Management and Treatment of Chronic Hepatitis C in HIV Patients

     Article • Seminars in Liver Disease, May 2012, Thieme Publishing Group

     Dr. Vicente Soriano

429. 
     Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress

     Article • Journal of Neurochemistry, April 2012, Wiley

     Dr. Vicente Soriano

430. 
     Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

     Article • Journal of Antimicrobial Chemotherapy, April 2012, Oxford University Press (OUP)

     Dr Alejandro J Krolewiecki, Dr. Vicente Soriano

431. 
     Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

     Article • Expert Opinion on Pharmacotherapy, April 2012, Informa Healthcare

     Dr. Vicente Soriano

432. 
     B3 Identification of Neutralizing Antibodies and Their Epitopes From HIV Controllers

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

433. 
     Intrapatient and Interpatient Pharmacokinetic Variability of Raltegravir in the Clinical Setting

     Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

434. 
     Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A

     Article • Journal of General Virology, April 2012, Society for General Microbiology

     Dr. Vicente Soriano

435. 
     Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

     Article • Journal of Hepatology, April 2012, Elsevier

     Dr. Vicente Soriano

436. 
     1376 LIVER TOXICITY OF THE MOST RECENTLY APPROVED ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS - OVERALL LOW RATE BUT INCREASED IN THE PRESENCE OF CHRONIC HEPATITIS C

     Article • Journal of Hepatology, April 2012, Elsevier

     Dr. Vicente Soriano

437. 
     906 RECOGNITION OF HEPATITIS C VIRUS (HCV) MINORITY STRAINS BY COLD-PCR

     Article • Journal of Hepatology, April 2012, Elsevier

     Dr. Vicente Soriano

438. 
     1420 THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2

     Article • Journal of Hepatology, April 2012, Elsevier

     Dr. Vicente Soriano

439. 
     Impact of Antiretroviral Therapy on Tuberculosis Incidence Among HIV-Positive Patients in High-Income Countries

     Article • Clinical Infectious Diseases, March 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

440. 
     Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms

     Article • Clinical Infectious Diseases, March 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

441. 
     Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

     Article • Antimicrobial Agents and Chemotherapy, March 2012, ASM Journals

     Dr. Vicente Soriano

442. 
     Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

     Article • Virology Journal, March 2012, Springer Science + Business Media

     Dr. Vicente Soriano

443. 
     Long-Term Use of Atazanavir in the Treament of HIV-Infected Patients

     Article • Clinical Medicine Insights Therapeutics, March 2012, SAGE Publications

     Dr. Vicente Soriano

444. 
     Drug resistance testing in hepatitis C therapy

     Article • Future Virology, March 2012, Future Medicine

     Dr. Vicente Soriano

445. 
     Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir

     Article • AIDS, March 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

446. 
     Factores sociodemográficos asociados a la progresión de la infección por VIH e impacto del TARGA en una cohorte de pacientes seroconvertores en Madrid (1986-2009)

     Article • Enfermedades Infecciosas y Microbiología Clínica, March 2012, Elsevier

     Dr. Vicente Soriano

447. 
     Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations

     Article • AIDS Research and Human Retroviruses, February 2012, Mary Ann Liebert Inc

     Dr. Vicente Soriano

448. 
     Impact of IL28B gene polymorphisms on interferon- 3 plasma levels during pegylated interferon- /ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

     Article • Journal of Antimicrobial Chemotherapy, January 2012, Oxford University Press (OUP)

     Dr. Vicente Soriano

449. 
     Treatment failure with new hepatitis C drugs

     Article • Expert Opinion on Pharmacotherapy, January 2012, Informa Healthcare

     Dr. Vicente Soriano

450. 
     Foreign Direct Investment vs. Foreign Portfolio Investment

     Article • Management International Review, January 2012, Springer Science + Business Media

     Dr. Vicente Soriano

451. 
     Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization

     Article • Allergy, January 2012, Wiley

     Dr. Vicente Soriano

452. 
     Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008–2010

     Article • Antiviral Therapy, January 2012, International Medical Press

     Dr. Vicente Soriano

453. 
     The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression

     Article • Antiviral Therapy, January 2012, International Medical Press

     Dr. Vicente Soriano

454. 
     Long-term exposure to combination antiretroviral therapy and risk of death from specific causes

     Article • AIDS, January 2012, Wolters Kluwer Health

     Dr. Vicente Soriano

455. 
     Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure

     Article • AIDS Research and Therapy, January 2012, Springer Science + Business Media

     Dr. Vicente Soriano

456. 
     Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

     Article • Antiviral Therapy, January 2012, International Medical Press

     Dr. Vicente Soriano

457. 
     Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex

     Article • Virology Journal, January 2012, Springer Science + Business Media

     Enrique J. Calderon, Dr. Vicente Soriano

458. 
     Pharmacogenetics of hepatitis C

     Article • Journal of Antimicrobial Chemotherapy, December 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

459. 
     Comparison of HIV-1 RNA Measurements Obtained by Using Plasma and Dried Blood Spots in the Automated Abbott Real-Time Viral Load Assay

     Article • Journal of Clinical Microbiology, December 2011, ASM Journals

     Dr. Vicente Soriano

460. 
     Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes

     Article • The Journal of Infectious Diseases, December 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

461. 
     Most HIV Type 1 Non-B Infections in the Spanish Cohort of Antiretroviral Treatment-Naive HIV-Infected Patients (CoRIS) Are Due to Recombinant Viruses

     Article • Journal of Clinical Microbiology, December 2011, ASM Journals

     Dr. Vicente Soriano

462. 
     Longitudinal Assessment of Interleukin 7 Plasma Levels in HIV-Infected Patients in the Absence of and Under Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

463. 
     Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy

     Article • Journal of Infection, November 2011, Elsevier

     Dr. Vicente Soriano

464. 
     Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata

     Article • AIDS, November 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

465. 
     La cohorte de la red española de investigación en sida y su biobanco: organización, principales resultados y pérdidas al seguimiento

     Article • Enfermedades Infecciosas y Microbiología Clínica, November 2011, Elsevier

     Dr. Vicente Soriano

466. 
     Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients

     Article • AIDS, November 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

467. 
     Host genetics

     Article • Current Opinion in HIV and AIDS, November 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

468. 
     Infección por virus de la inmunodeficiencia humana y hepatitis víricas

     Article • Enfermedades Infecciosas y Microbiología Clínica, November 2011, Elsevier

     Dr. Vicente Soriano

469. 
     Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

     Article • Clinical Infectious Diseases, October 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

470. 
     The expansion ability but not the quality of HIV-specific CD8+ T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

     Article • Immunology, October 2011, Wiley

     Dr. Vicente Soriano

471. 
     HTLV infection among foreign pregnant women living in Spain

     Article • Journal of Clinical Virology, October 2011, Elsevier

     Dr. Vicente Soriano

472. 
     Hepatitis delta in HIV-infected individuals in Europe

     Article • AIDS, October 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

473. 
     Profilaxis preexposición en la prevención de la infección por virus de la inmunodeficiencia humana

     Article • Medicina Clínica, October 2011, Elsevier

     Dr. Vicente Soriano

474. 
     Response to: “Is the Study Power Enough to Say ‘No Difference’?” by Geib et al

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

475. 
     Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy

     Article • AIDS Research and Human Retroviruses, October 2011, Mary Ann Liebert Inc

     Dr. Vicente Soriano

476. 
     Antiviral effect of raltegravir on HTLV-1 carriers

     Article • Journal of Antimicrobial Chemotherapy, September 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

477. 
     Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

     Article • Journal of Antimicrobial Chemotherapy, September 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

478. 
     A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

     Article • Nature Genetics, September 2011, Springer Science + Business Media

     Professor Ulla B Vogel, Dr Karina Banasik, Dr. Vicente Soriano

479. 
     A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy

     Article • The Journal of Infectious Diseases, September 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

480. 
     Short Communication: Severe Immune Suppression in Patients Infected with R5-Tropic HIV-1 Strains Is Associated with Increased gp120 Net Charge at Variable Regions

     Article • AIDS Research and Human Retroviruses, September 2011, Mary Ann Liebert Inc

     Dr. Vicente Soriano

481. 
     The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

     Article • Journal of Viral Hepatitis, August 2011, Wiley

     Dr. Vicente Soriano

482. 
     An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHIEV2E Quality Control Study

     Article • Journal of Clinical Microbiology, August 2011, ASM Journals

     Dr. Vicente Soriano

483. 
     Comparison of Two Serological Tests for the Identification of Recent HIV Infection: Vironostika HIV-1 Microelisa and BED Capture Enzyme Immunoassay

     Article • Enfermedades Infecciosas y Microbiología Clínica, August 2011, Elsevier

     Dr Jesus Almeda, Dr. Vicente Soriano

484. 
     High Concordance between the Position-Specific Scoring Matrix and Geno2pheno Algorithms for Genotypic Interpretation of HIV-1 Tropism: V3 Length as the Major Cause of Disagreement: Table 1.

     Article • Journal of Clinical Microbiology, July 2011, ASM Journals

     Dr. Vicente Soriano

485. 
     Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: The INSIGHT FLU 002 and FLU 003 studies

     Article • Vaccine, July 2011, Elsevier

     Dr. Vicente Soriano

486. 
     Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction

     Article • The Journal of Infectious Diseases, July 2011, Oxford University Press (OUP)

     Neill Liptrott, Dr. Vicente Soriano

487. 
     Tuberculosis among HIV-positive patients across Europe

     Article • AIDS, July 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

488. 
     Seroprevalence of HTLV infection among immigrant pregnant women in the Mediterranean coast of Spain

     Article • Journal of Clinical Virology, July 2011, Elsevier

     Dr. Vicente Soriano

489. 
     Directly acting antivirals against hepatitis C virus

     Article • Journal of Antimicrobial Chemotherapy, June 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

490. 
     Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain

     Article • Retrovirology, June 2011, Springer Science + Business Media

     Dr. Vicente Soriano

491. 
     Seroprevalence of HTLV infection in Spain among immigrant pregnant women

     Article • Retrovirology, June 2011, Springer Science + Business Media

     Dr. Vicente Soriano

492. 
     Treatment with Raltegravir, a retroviral integrase inhibitor, in patients infected with HTLV-1

     Article • Retrovirology, June 2011, Springer Science + Business Media

     Dr. Vicente Soriano

493. 
     Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

     Article • AIDS, June 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

494. 
     Changing Rate of Non-B Subtypes and Coinfection with Hepatitis B/C Viruses in Newly Diagnosed HIV Type 1 Individuals in Spain

     Article • AIDS Research and Human Retroviruses, June 2011, Mary Ann Liebert Inc

     Dr. Vicente Soriano

495. 
     Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy

     Article • The Journal of Infectious Diseases, June 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

496. 
     Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients – Impact of HIV subtypes and prior raltegravir experience

     Article • Antiviral Research, June 2011, Elsevier

     Dr. Vicente Soriano

497. 
     Perspectivas futuras en el tratamiento de la hepatitis crónica C

     Article • Revista Española de Sanidad Penitenciaria, June 2011, Instituto de Salud Carlos III/BNCS/SciELO Espana

     Dr. Vicente Soriano

498. 
     Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3′Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antire...

     Article • Antimicrobial Agents and Chemotherapy, May 2011, ASM Journals

     Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

499. 
     Impact of Baseline HIV-1 Tropism on Viral Response and CD4 Cell Count Gains in HIV-Infected Patients Receiving First-line Antiretroviral Therapy

     Article • The Journal of Infectious Diseases, May 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

500. 
     Drug resistance mutations in patients infected with HIV-2 living in Spain

     Article • Journal of Antimicrobial Chemotherapy, May 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

501. 
     HIV and the Liver

     Article • May 2011, Wiley

     Dr. Vicente Soriano

502. 
     Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

     Article • AIDS, May 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

503. 
     European guidelines on the clinical management of HIV-1 tropism testing

     Article • The Lancet Infectious Diseases, May 2011, Elsevier

     Dr. Vicente Soriano

504. 
     HCV-Specific T-Cell Responses in HIV/Hepatitis C Virus-Coinfected Patients on Highly Active Antiretroviral Therapy Are Comparable to Those Observed in Hepatitis C Virus-Monoinfected Individuals

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

505. 
     IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin

     Article • AIDS, May 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

506. 
     Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors

     Article • Clinical Immunology, May 2011, Elsevier

     Dr. Vicente Soriano

507. 
     XMRV, un nuevo retrovirus humano en busca de enfermedad

     Article • Medicina Clínica, May 2011, Elsevier

     Dr. Vicente Soriano

508. 
     Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

     Article • HIV Medicine, April 2011, Wiley

     Dr. Vicente Soriano

509. 
     Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2-Infected Patients: The ACHIEV2E Collaboration Study Group

     Article • Clinical Infectious Diseases, April 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

510. 
     Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

     Article • Journal of Viral Hepatitis, April 2011, Wiley

     Dr. Vicente Soriano

511. 
     A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study

     Article • HIV Clinical Trials, April 2011, Taylor & Francis

     Dr. Vicente Soriano

512. 
     New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B

     Article • AIDS, April 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

513. 
     Documento de consenso de GESIDA/ Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2011)

     Article • Enfermedades Infecciosas y Microbiología Clínica, March 2011, Elsevier

     Dr. Vicente Soriano

514. 
     Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

     Article • HIV Medicine, March 2011, Wiley

     Dr. Vicente Soriano

515. 
     Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression

     Article • Virology, March 2011, Elsevier

     Dr. Vicente Soriano

516. 
     Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

     Article • AIDS, March 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

517. 
     1168 SURVIVAL OF HIV AND HIV/HCV CO-INFECTED PATIENTS WITHIN INTENSIVE CARE UNIT (ICU) IN THE MOST RECENT HAART ERA

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

518. 
     1230 IMPACT OF ANTIRETROVIRAL THERAPY ON THE VARIABILITY OF THE HCV NS5B POLYMERASE IN HIV/HCV COINFECTED PATIENTS

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

519. 
     1335 IL28B POLYMORPHISM IN HIV-POSITIVE PATIENTS WITH ACUTE HEPATITIS C

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

520. 
     1321 DIFFERENT INFLUENCE OF HCV-SPECIFIC T-CELL RESPONSES AND RS12979860 IL28B GENOTYPES ON KINETICS OF HCV CLEARANCE IN PATIENTS TREATED WITH PEGINTERFERON-RIBAVIRIN

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

521. 
     354 LIVER FIBROSIS PROGRESSION IN HIV+ PATIENTS UNDER DISTINCT ANTIRETROVIRAL DRUGS

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

522. 
     1338 WHOLE GENOME EXPRESSION PROFILE DEFINES DIFFERENTIALLY EXPRESSED GENES IN HIV/HCV-COINFECTED PATIENTS ACCORDING TO PEGIFNA/RBV TREATMENT OUTCOME AND TO IL28B GENOTYPE

     Article • Journal of Hepatology, March 2011, Elsevier

     Dr. Vicente Soriano

523. 
     Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

     Article • Expert Opinion on Drug Metabolism & Toxicology, February 2011, Informa Healthcare

     Dr. Vicente Soriano

524. 
     Elite Controllers Display Higher Activation on Central Memory CD8 T Cells Than HIV Patients Successfully on HAART

     Article • AIDS Research and Human Retroviruses, February 2011, Mary Ann Liebert Inc

     Dr. Vicente Soriano

525. 
     Noncirrhotic portal hypertension in HIV infection

     Article • Current Opinion in Infectious Diseases, February 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

526. 
     Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

     Article • Journal of Antimicrobial Chemotherapy, January 2011, Oxford University Press (OUP)

     Dr. Vicente Soriano

527. 
     HCV and HIV Coinfection

     Article • Current Hepatology Reports, January 2011, Springer Science + Business Media

     Dr. Vicente Soriano

528. 
     A Highly Sensitive and Specific Model for Predicting HIV-1 Tropism in Treatment-Experienced Patients Combining Interpretation of V3 Loop Sequences and Clinical Parameters

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2011, Wolters Kluwer Health

     Dr Mar Masiá, Blanca Lumbreras, Dr. Vicente Soriano

529. 
     Sub-Cellular Distribution and Translocation of TRP Channels

     Article • Current Pharmaceutical Biotechnology, January 2011, Bentham Science Publishers

     Dr. Vicente Soriano

530. 
     Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

531. 
     Predicted effect of direct acting antivirals in the current HIV–HCV-coinfected population in Spain

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

532. 
     Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

     Article • AIDS, January 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

533. 
     HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

534. 
     Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

535. 
     Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline

     Article • AIDS, January 2011, Wolters Kluwer Health

     Dr. Vicente Soriano

536. 
     Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV–HCV-coinfected patients

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

537. 
     Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

538. 
     Resistance data in the ARTEN trial

     Article • Antiviral Therapy, January 2011, International Medical Press

     Dr. Vicente Soriano

539. 
     Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS)

     Article • Antiviral Research, January 2011, Elsevier

     Dr. Vicente Soriano

540. 
     Infrared Focal Plane Array Imaging System Characterization by Means of a Blackbody Radiator

     Article • January 2011, Springer Science + Business Media

     Dr. Vicente Soriano

541. 
     Resistance data in the ARTEN trial

     Article • Antiviral Therapy, January 2011, SAGE Publications

     Dr. Vicente Soriano

542. 
     Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain

     Article • Journal of Antimicrobial Chemotherapy, December 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

543. 
     Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

     Article • Journal of Viral Hepatitis, December 2010, Wiley

     Dr. Vicente Soriano

544. 
     Acute hepatitis C in HIV-infected individuals – recommendations from the NEAT consensus conference

     Article • AIDS, December 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

545. 
     Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

546. 
     Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV

     Article • Clinical Infectious Diseases, November 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

547. 
     Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes

     Article • Journal of Viral Hepatitis, November 2010, Wiley

     Dr. Vicente Soriano

548. 
     Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

     Article • Journal of the International AIDS Society, November 2010, Wiley

     Dr Victor Asensi, Dr. Vicente Soriano

549. 
     Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants

     Article • Antiviral Research, November 2010, Elsevier

     Dr. Vicente Soriano

550. 
     Efficacy of Exercise in Reducing Depressive Symptoms across 5-HTTLPR Genotypes

     Article • Medicine & Science in Sports & Exercise, November 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

551. 
     Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon–Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection

     Article • The Journal of Infectious Diseases, October 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

552. 
     Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

     Article • Journal of Antimicrobial Chemotherapy, October 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

553. 
     Near-Membrane Dynamics and Capture of TRPM8 Channels within Transient Confinement Domains

     Article • PLOS One, October 2010, PLOS

     Dr. Vicente Soriano

554. 
     Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance

     Article • Antimicrobial Agents and Chemotherapy, October 2010, ASM Journals

     Dr. Vicente Soriano

555. 
     Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

     Article • European Journal of Cardiovascular Prevention & Rehabilitation, October 2010, SAGE Publications

     Dr. Vicente Soriano

556. 
     Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

557. 
     European guideline for the management of hepatitis B and C virus infections, 2010

     Article • International Journal of STD & AIDS, October 2010, SAGE Publications

     Dr. Vicente Soriano

558. 
     Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

     Article • European Journal of Clinical Investigation, September 2010, Wiley

     Dr. Vicente Soriano

559. 
     Evolution of the Functional Profile of HIV-Specific CD8+ T Cells in Patients With Different Progression of HIV Infection Over 4 Years

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

560. 
     Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis

     Article • Journal of Viral Hepatitis, August 2010, Wiley

     Dr. Vicente Soriano

561. 
     A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

     Article • HIV Medicine, August 2010, Wiley

     Dr. Vicente Soriano

562. 
     Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)

     Article • HIV Medicine, August 2010, Wiley

     Dr. Vicente Soriano

563. 
     Situación actual de la infección por el virus de la inmunodeficiencia humana tipo 2 y el Virus linfotrópico de células T humano en España

     Article • Enfermedades Infecciosas y Microbiología Clínica, August 2010, Elsevier

     Dr. Vicente Soriano

564. 
     Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey

     Article • AIDS Research and Human Retroviruses, August 2010, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Enrique J. Calderon

565. 
     RETRACTED ARTICLE: Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial

     Article • HIV Clinical Trials, August 2010, Taylor & Francis

     Dr. Vicente Soriano

566. 
     Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

     Article • Cancer, July 2010, Wiley

     Dr. Vicente Soriano

567. 
     High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists--authors' response

     Article • Journal of Antimicrobial Chemotherapy, July 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

568. 
     Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

     Article • The Lancet, July 2010, Elsevier

     Dr. Vicente Soriano

569. 
     Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

     Article • AIDS, July 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

570. 
     Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

     Article • The Lancet, July 2010, Elsevier

     Dr. Vicente Soriano

571. 
     Resistance to Integrase Inhibitors

     Article • Viruses, June 2010, MDPI AG

     Dr. Vicente Soriano

572. 
     Low-Level Exposure to HIV Induces Virus-Specific T Cell Responses and Immune Activation in Exposed HIV-Seronegative Individuals

     Article • The Journal of Immunology, June 2010, The American Association of Immunologists

     Dr. Vicente Soriano

573. 
     Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701

     Article • Journal of Antimicrobial Chemotherapy, June 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

574. 
     Documento de consenso del Grupo de Estudio de Sida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2010)

     Article • Enfermedades Infecciosas y Microbiología Clínica, June 2010, Elsevier

     Dr. Vicente Soriano

575. 
     Nuevos retrovirus humanos

     Article • Medicina Clínica, June 2010, Elsevier

     Dr. Vicente Soriano

576. 
     Infección por el virus de la inmunodeficiencia humana de tipo 2 (VIH-2) y los virus linfotrópico humano de células T de tipos 1 y 2 (HTLV-1/2) en España

     Article • Medicina Clínica, June 2010, Elsevier

     Dr. Vicente Soriano

577. 
     Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia

     Article • Journal of Antimicrobial Chemotherapy, May 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

578. 
     Plitidepsin (APL) alone or with dacarbazine (DTIC) as first-line treatment for advanced unresectable melanoma (AUM).

     Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

     Dr. Vicente Soriano

579. 
     Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy

     Article • Antimicrobial Agents and Chemotherapy, May 2010, ASM Journals

     Dr. Vicente Soriano

580. 
     Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

     Article • Retrovirology, May 2010, Springer Science + Business Media

     Dr. Vicente Soriano

581. 
     Hepatitis B: treatment strategies and resistance

     Article • Retrovirology, May 2010, Springer Science + Business Media

     Dr. Vicente Soriano

582. 
     Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

     Article • Retrovirology, May 2010, Springer Science + Business Media

     Dr. Vicente Soriano

583. 
     Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

     Article • AIDS, May 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

584. 
     Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

     Article • AIDS, May 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

585. 
     High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

     Article • Journal of Antimicrobial Chemotherapy, April 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

586. 
     Renal toxicity associated with tenofovir use

     Article • Expert Opinion on Drug Safety, April 2010, Informa Healthcare

     Dr. Vicente Soriano

587. 
     Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

588. 
     Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004–2008

     Article • Medicina Clínica, April 2010, Elsevier

     Dr. Vicente Soriano

589. 
     Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

     Article • AIDS, April 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

590. 
     Preemptive Erythropoietin Plus High Ribavirin Doses to Increase Rapid Virological Responses in HIV Patients Treated for Chronic Hepatitis C

     Article • AIDS Research and Human Retroviruses, April 2010, Mary Ann Liebert Inc

     Dr. Vicente Soriano

591. 
     275 TREATMENT OF CHRONIC HEPATITIS C IN HIV-INFECTED PATIENTS WITH COMPENSATED LIVER CIRRHOSIS

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

592. 
     1008 KIDNEY TUBULAR DYSFUNCTION (KTD) IN PATIENTS WITH PROLONGED EXPOSURE TO TENOFOVIR (TDF): A PROSPECTIVE STUDY

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

593. 
     1159 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS: UNIQUE CLINICAL AND PATHOLOGICAL FEATURES

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

594. 
     1160 HEPATIC SAFETY PROFILE OF NEW ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

595. 
     282 A SPECIFIC HAPLOTYPE AT THE ENT1 GENE INFLUENCES THE RATE OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON-RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

596. 
     715 ASSESSMENT OF THE VIROLOGICAL PROFILES OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) REQUIRES LONGITUDINAL MEASUREMENTS OF HBV DNA AND HDV RNA

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

597. 
     743 NATURALLY OCCURRING DRUG RESISTANCE MUTATIONS IN THE HEPATITIS C VIRUS NS3 PROTEASE IN HIV/HCV COINFECTED PATIENTS TREATED WITH HIV PROTEASE INHIBITORS

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

598. 
     1085 VIRAL HEPATITIS B AND C IN NEWLY DIAGNOSED HIV-1 INDIVIDUALS IN SPAIN – A NATIONAL SURVEY SINCE YEAR 2000

     Article • Journal of Hepatology, April 2010, Elsevier

     Dr. Vicente Soriano

599. 
     Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

     Article • AIDS, March 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

600. 
     Human immunodeficiency virus and liver disease: Conference proceedings

     Article • Hepatology, March 2010, Wiley

     Dr. Vicente Soriano

601. 
     Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

602. 
     Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

     Article • AIDS, March 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

603. 
     Survival of HIV-infected patients with compensated liver cirrhosis

     Article • AIDS, March 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

604. 
     The Benefit of Simplification From Tipranavir/Ritonavir 500/200 bid to 500/100 bid Guided by Therapeutic Drug Monitoring

     Article • Therapeutic Drug Monitoring, March 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

605. 
     Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

     Article • Clinical Infectious Diseases, February 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

606. 
     History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

     Article • HIV Medicine, February 2010, Wiley

     Dr. Vicente Soriano

607. 
     Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

     Article • Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals

     Dr. Vicente Soriano

608. 
     New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients

     Article • Journal of Antimicrobial Chemotherapy, January 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

609. 
     Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

     Article • Journal of Antimicrobial Chemotherapy, January 2010, Oxford University Press (OUP)

     Dr. Vicente Soriano

610. 
     Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia

     Article • Journal of the International AIDS Society, January 2010, Wiley

     Dr. Vicente Soriano

611. 
     Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients

     Article • Journal of the International AIDS Society, January 2010, Wiley

     Dr. Vicente Soriano

612. 
     Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing

     Article • Journal of the International AIDS Society, January 2010, Wiley

     Dr. Vicente Soriano

613. 
     Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

     Article • Journal of the International AIDS Society, January 2010, Wiley

     Dr. Vicente Soriano

614. 
     No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

     Article • Journal of the International AIDS Society, January 2010, Wiley

     Dr. Vicente Soriano

615. 
     Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure

     Article • Retrovirology, January 2010, Springer Science + Business Media

     Dr. Vicente Soriano

616. 
     High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

     Article • AIDS, January 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

617. 
     The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

     Article • AIDS, January 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

618. 
     Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

     Article • AIDS, January 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

619. 
     High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor

     Article • AIDS, January 2010, Wolters Kluwer Health

     Dr. Vicente Soriano

620. 
     Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

     Article • Antiviral Therapy, January 2010, International Medical Press

     Dr. Vicente Soriano

621. 
     Viral hepatitis and HIV co-infection

     Article • Antiviral Research, January 2010, Elsevier

     Dr. Vicente Soriano

622. 
     TRPM8 Near-Membrane Dynamics and Channel Stabilization after Stimulation

     Article • Biophysical Journal, January 2010, Elsevier

     Dr. Vicente Soriano

623. 
     Genotype Testing to Determine HIV Coreceptor Tropism

     Article • International Journal of Clinical Reviews, January 2010, Remedica Medical Education and Publishing

     Dr. Vicente Soriano

624. 
     Update on HIV and HCV coinfection

     Article • Hot Topics in Viral Hepatitis, January 2010, FB Communication

     Dr. Vicente Soriano

625. 
     Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

     Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

626. 
     New therapeutic strategies for raltegravir

     Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

627. 
     Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection

     Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

628. 
     Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations

     Article • Journal of Viral Hepatitis, December 2009, Wiley

     Dr. Vicente Soriano

629. 
     Short Communication: Transmission of Hepatitis B Viruses with Lamivudine Resistance Mutations in Newly Diagnosed HIV Individuals

     Article • AIDS Research and Human Retroviruses, December 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano

630. 
     Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

     Article • Journal of Viral Hepatitis, November 2009, Wiley

     Dr. Vicente Soriano

631. 
     Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected Patients

     Article • Clinical Infectious Diseases, November 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

632. 
     El desafío de la nueva gripe A/H1N1

     Article • Medicina Clínica, November 2009, Elsevier

     Dr. Vicente Soriano

633. 
     When and how to use maraviroc in HIV-infected patients

     Article • AIDS, November 2009, Wolters Kluwer Health

     Dr. Vicente Soriano

634. 
     Interleukin-2 Therapy in Patients with HIV Infection

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2009, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

635. 
     Fe de errores de “Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)”

     Article • Enfermedades Infecciosas y Microbiología Clínica, October 2009, Elsevier

     Dr. Vicente Soriano

636. 
     Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain

     Article • AIDS Research and Human Retroviruses, October 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano

637. 
     Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity

     Article • Journal of Clinical Virology, October 2009, Elsevier

     Dr. Vicente Soriano

638. 
     Pharmacogenetics of tenofovir treatment

     Article • Pharmacogenomics, October 2009, Future Medicine

     Dr. Vicente Soriano

639. 
     Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited Settings

     Article • The Journal of Infectious Diseases, September 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

640. 
     First HAART in HIV-Infected Patients With High Viral Load: Value of HIV RNA Levels at 12 Weeks to Predict Virologic Outcome

     Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), September 2009, SAGE Publications

     Dr. Vicente Soriano

641. 
     Update on HIV viral-load assays: new technologies and testing in resource-limited settings

     Article • Future Virology, September 2009, Future Medicine

     Dr. Vicente Soriano

642. 
     Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

     Article • AIDS, August 2009, Wolters Kluwer Health

     Dr. Vicente Soriano

643. 
     Actualización sobre las infecciones por el virus de la inmunodeficiencia humana de tipo 2 y por los virus linfotrópico humano de tipo 1 y de tipo 2 en España

     Article • Enfermedades Infecciosas y Microbiología Clínica, August 2009, Elsevier

     Dr. Vicente Soriano

644. 
     Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

     Article • Antimicrobial Agents and Chemotherapy, July 2009, ASM Journals

     Dr. Vicente Soriano

645. 
     HIV protease inhibitors: recent clinical trials and recommendations on use

     Article • Expert Opinion on Pharmacotherapy, June 2009, Informa Healthcare

     Dr. Vicente Soriano

646. 
     Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance

     Article • Journal of Antimicrobial Chemotherapy, June 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

647. 
     Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

     Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

648. 
     Seroprevalence of HTLV-1/2 Infection among Native and Immigrant Pregnant Women in Spain

     Article • AIDS Research and Human Retroviruses, June 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Enrique J. Calderon

649. 
     Seroreversion of Hepatitis C Virus (HCV) Antibodies in an HIV‐Infected Patient despite Continuous HCV Replication

     Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

650. 
     Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

     Article • Retrovirology, May 2009, Springer Science + Business Media

     Dr Dimitrios Paraskevis, Dr. Vicente Soriano

651. 
     Reply to Pascual Pareja et al.

     Article • The Journal of Infectious Diseases, May 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

652. 
     The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies

     Article • Vaccine, May 2009, Elsevier

     Dr. Vicente Soriano

653. 
     Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

     Article • Journal of Medical Virology, May 2009, Wiley

     Dr. Vicente Soriano

654. 
     Metodología de reclutamiento y características de una cohorte de jóvenes consumidores habituales de cocaína de tres ciudades españolas (Proyecto Itínere-cocaína)

     Article • Gaceta Sanitaria, May 2009, Elsevier

     Dr. Vicente Soriano

655. 
     Variable Impact on Mortality of AIDS‐Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS‐Defining Conditions Are Created Equal

     Article • Clinical Infectious Diseases, April 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

656. 
     227 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr Victor Asensi, Dr. Vicente Soriano

657. 
     Differences in Lopinavir Plasma Concentrations Comparing Kaletra® Film Coated Tablets and Soft Gelatine Capsules That Result in Various Lipid Abnormalities

     Article • Drug Metabolism Letters, April 2009, Bentham Science Publishers

     Dr. Vicente Soriano

658. 
     Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)

     Article • Enfermedades Infecciosas y Microbiología Clínica, April 2009, Elsevier

     Dr. Vicente Soriano

659. 
     Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2009, Wolters Kluwer Health

     Dr. Vicente Soriano

660. 
     Liver Complications Have Reached a Plateau as Cause of Hospital Admission and Death in HIV Patients in Madrid

     Article • AIDS Research and Human Retroviruses, April 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano

661. 
     Transmisión vertical del virus de la inmunodeficiencia humana en la era del tratamiento antirretroviral de gran actividad

     Article • Medicina Clínica, April 2009, Elsevier

     Dr. Vicente Soriano

662. 
     343 NO EVIDENCE FOR LOW-LEVEL HCV REPLICATION OR SIGNIFICANT LIVER FIBROSIS IN HIV PATIENTS WHO SPONTANEOUSLY CLEARED HCV INFECTION

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr. Vicente Soriano

663. 
     648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETWEEN PEGYLATED INTERFERON ALPHA – 2A AND – 2B IN HIV INFECTED PATIENTS WITH CHRONIC HEPATITIS C

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr. Vicente Soriano

664. 
     888 ASSOCIATION BETWEEN NAIVE REGULATORY T (TREG) CELLS AND HCV-SPECIFIC IMMUNE RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS C

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr. Vicente Soriano

665. 
     887 HCV-SPECIFIC T CELL RESPONSE IN PATIENTS WITH CHRONIC HIV/HCV CO-INFECTION IS NOT DEPENDENT OF HCV GENOTYPE

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr. Vicente Soriano

666. 
     411 HEPATITIS C VIRUS REAPPEARANCE IN HIV-INFECTED PATIENTS WITH SPONTANEOUS HCV-RNA CLEARANCE

     Article • Journal of Hepatology, April 2009, Elsevier

     Dr. Vicente Soriano

667. 
     Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists

     Article • Journal of Antimicrobial Chemotherapy, March 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

668. 
     Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality

     Article • Current HIV Research, March 2009, Bentham Science Publishers

     Dr. Vicente Soriano

669. 
     Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

     Article • AIDS, March 2009, Wolters Kluwer Health

     Dr. Vicente Soriano

670. 
     Lack of Significant Cross-Reactivity for HIV-2 Immunoblots in HIV-1-Infected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2009, Wolters Kluwer Health

     Dr. Vicente Soriano

671. 
     Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

     Article • Journal of Clinical Microbiology, February 2009, ASM Journals

     Dr. Vicente Soriano

672. 
     Fourth HIV & Hepatitis Coinfection Workshop; June 19–21, 2008; Madrid, Spain

     Article • HIV Clinical Trials, February 2009, Taylor & Francis

     Dr. Vicente Soriano

673. 
     Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study)

     Article • HIV Clinical Trials, February 2009, Taylor & Francis

     Dr. Vicente Soriano

674. 
     New Therapies for Hepatitis C Virus Infection

     Article • Clinical Infectious Diseases, February 2009, Oxford University Press (OUP)

     Dr. Vicente Soriano

675. 
     Raltegravir and Etravirine Are Active against HIV Type 1 Group O

     Article • AIDS Research and Human Retroviruses, February 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano

676. 
     Non-covalent functionalization of carbon nanotubes with glycolipids: glyconanomaterials with specific lectin-affinity

     Article • Soft Matter, January 2009, Royal Society of Chemistry

     Dr. Vicente Soriano, Mohyeddin Assali

677. 
     Clinical Differences and Viral Diversity between Newly HIV Type 1-Diagnosed African and Non-African Patients in Spain (2005–2007)

     Article • AIDS Research and Human Retroviruses, January 2009, Mary Ann Liebert Inc

     Dr. Vicente Soriano

678. 
     Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program

     Article • Enfermedades Infecciosas y Microbiología Clínica, January 2009, Elsevier

     Dr. Vicente Soriano

679. 
     Injecting, Sexual Risk Behaviors and HIV Infection in Young Cocaine and Heroin Users in Spain

     Article • European Addiction Research, January 2009, Karger Publishers

     Dr. Vicente Soriano

680. 
     Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus

     Article • Clinical & Experimental Immunology, January 2009, Wiley

     Dr. Vicente Soriano

681. 
     Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients

     Article • HIV Medicine, January 2009, Wiley

     Dr. Vicente Soriano

682. 
     Role of atazanavir in the treatment of HIV infection

     Article • Therapeutics and Clinical Risk Management, December 2008, Dove Medical Press

     Dr. Vicente Soriano

683. 
     Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study

     Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

684. 
     Editorial Commentary:Risks and Benefits of Using Antiretroviral Therapy in HIV‐Infected Patients with Chronic Hepatitis B in Developing Regions

     Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

685. 
     Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients

     Article • HIV Clinical Trials, December 2008, Taylor & Francis

     Dr. Vicente Soriano

686. 
     Resistencia viral y barrera genética de atazanavir

     Article • Enfermedades Infecciosas y Microbiología Clínica, December 2008, Elsevier

     Dr. Vicente Soriano

687. 
     Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation

     Article • Molecular Neurodegeneration, December 2008, Springer Science + Business Media

     Dr. Vicente Soriano

688. 
     Down‐Regulation of Interleukin‐7 Receptor (CD127) in HIV Infection Is Associated with T Cell Activation and Is a Main Factor Influencing Restoration of CD4+Cells after Antiretroviral Therapy

     Article • The Journal of Infectious Diseases, November 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

689. 
     Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion

     Article • Sexually Transmitted Infections, November 2008, BMJ

     Dr Jesus Almeda, Dr. Vicente Soriano

690. 
     Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

     Article • AIDS, November 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

691. 
     Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

     Article • AIDS, November 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

692. 
     Diagnóstico de las infecciones por subtipos no B del VIH-1 y por VIH-2

     Article • Enfermedades Infecciosas y Microbiología Clínica, November 2008, Elsevier

     Dr. Vicente Soriano

693. 
     Optimal use of maraviroc in clinical practice

     Article • AIDS, November 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

694. 
     Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

     Article • AIDS, November 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

695. 
     Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

     Article • AIDS, November 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

696. 
     Resistencia a los inhibidores de la integrasa

     Article • Enfermedades Infecciosas y Microbiología Clínica, November 2008, Elsevier

     Dr. Vicente Soriano

697. 
     Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe

     Article • The Journal of Infectious Diseases, November 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

698. 
     Reliability of Rapid Subtyping Tools Compared to That of Phylogenetic Analysis for Characterization of Human Immunodeficiency Virus Type 1 Non-B Subtypes and Recombinant Forms

     Article • Journal of Clinical Microbiology, October 2008, ASM Journals

     Dr. Vicente Soriano

699. 
     Current trends in screening across ethnicities for hypersensitivity to abacavir

     Article • Pharmacogenomics, October 2008, Future Medicine

     Dr. Vicente Soriano

700. 
     HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

     Article • AIDS, October 2008, Wolters Kluwer Health

     Dr. Vicente Soriano, Dr Frank van Leth

701. 
     Low Rate of Adverse Hepatic Events Associated with Fosamprenavir/Ritonavir-Based Antiretroviral Regimens

     Article • HIV Clinical Trials, October 2008, Taylor & Francis

     Dr. Vicente Soriano

702. 
     Maraviroc: farmacocinética, interacciones y mecanismo de acción

     Article • Enfermedades Infecciosas y Microbiología Clínica, October 2008, Elsevier

     Dr. Vicente Soriano

703. 
     Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4

     Article • Journal of Viral Hepatitis, October 2008, Wiley

     Dr. Vicente Soriano

704. 
     Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28–30, 2008

     Article • HIV Clinical Trials, October 2008, Taylor & Francis

     Dr. Vicente Soriano

705. 
     Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C

     Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

706. 
     Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

     Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

707. 
     Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C

     Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

708. 
     Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy

     Article • AIDS, September 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

709. 
     Short Communication: HIV Rebound after Discontinuation of Antiretroviral Therapy Increases and Expands HIV-Specific CD8+ Responses But Has No Impact on Its Functionality

     Article • AIDS Research and Human Retroviruses, September 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano

710. 
     No Major Differences in the Functional Profile of HIV Gag and Nef-Specific CD8+ Reponses between Long-Term Nonprogressors and Typical Progressors

     Article • AIDS Research and Human Retroviruses, September 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano

711. 
     Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients

     Article • Journal of Hepatology, September 2008, Elsevier

     Dr. Vicente Soriano

712. 
     Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2008, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

713. 
     Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2008, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

714. 
     Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, Testing HIV-1 Non-B Subtypes and Recombinant Variants

     Article • Journal of Clinical Microbiology, July 2008, ASM Journals

     Dr. Vicente Soriano

715. 
     Increase of Non-B Subtypes and Recombinants Among Newly Diagnosed HIV-1 Native Spaniards and Immigrants in Spain

     Article • Current HIV Research, July 2008, Bentham Science Publishers

     Dr. Vicente Soriano

716. 
     Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel

     Article • AIDS, July 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

717. 
     Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

     Article • Blood Coagulation & Fibrinolysis, July 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

718. 
     Hepatitis C Virus Coinfection Does Not Affect CD4 Restoration in HIV-Infected Patients after Initiation of Antiretroviral Therapy

     Article • AIDS Research and Human Retroviruses, July 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano

719. 
     Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years

     Article • AIDS, July 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

720. 
     Management of Chronic Hepatitis C Virus Infection in HIV‐Infected Patients

     Article • Clinical Infectious Diseases, July 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

721. 
     Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

722. 
     Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

     Article • Journal of Antimicrobial Chemotherapy, June 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

723. 
     Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir

     Article • Journal of Antimicrobial Chemotherapy, June 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

724. 
     Changing Patterns in HIV Reverse Transcriptase Resistance Mutations after Availability of Tenofovir

     Article • Clinical Infectious Diseases, June 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

725. 
     Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs

     Article • Journal of Substance Abuse Treatment, June 2008, Elsevier

     Dr. Vicente Soriano

726. 
     Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

     Article • Journal of Viral Hepatitis, June 2008, Wiley

     Dr. Vicente Soriano

727. 
     Papel de tenofovir en la coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C

     Article • Enfermedades Infecciosas y Microbiología Clínica, June 2008, Elsevier

     Dr. Vicente Soriano

728. 
     Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring

     Article • AIDS Research and Human Retroviruses, June 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano

729. 
     Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin

     Article • Journal of Viral Hepatitis, May 2008, Wiley

     Dr Victor Asensi, Dr. Vicente Soriano

730. 
     Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B

     Article • Journal of Viral Hepatitis, May 2008, Wiley

     Dr. Vicente Soriano

731. 
     Presentación

     Article • Enfermedades Infecciosas y Microbiología Clínica, May 2008, Elsevier

     Dr. Vicente Soriano

732. 
     Management of hepatitis B virus co-infection on and off antiretroviral therapy

     Article • Current HIV/AIDS Reports, May 2008, Springer Science + Business Media

     Dr. Vicente Soriano

733. 
     Profile of Patients Triply Infected with HIV and the Hepatitis B and C Viruses in the HAART Era

     Article • AIDS Research and Human Retroviruses, May 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Victor Sanchez Margalet

734. 
     Resistencias en el virus de la hepatitis B

     Article • Enfermedades Infecciosas y Microbiología Clínica, May 2008, Elsevier

     Dr. Vicente Soriano

735. 
     Farmacogenética de la respuesta al tratamiento antirretroviral

     Article • Enfermedades Infecciosas y Microbiología Clínica, May 2008, Elsevier

     Dr. Vicente Soriano

736. 
     Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8+ T cells

     Article • European Journal of Immunology, April 2008, Wiley

     Dr. Vicente Soriano

737. 
     A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1

     Article • AIDS, April 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

738. 
     Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

     Article • Journal of Antimicrobial Chemotherapy, April 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

739. 
     Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid‐Lowering Drugs in HIV‐Infected Individuals and Impact on Myocardial Infarction

     Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

740. 
     Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir

     Article • Antiviral Therapy, April 2008, SAGE Publications

     Dr. Vicente Soriano

741. 
     Short Communication: Association between Tipranavir Plasma Levels and Virological Response in HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, March 2008, Mary Ann Liebert Inc

     Dr. Vicente Soriano

742. 
     Emerging drugs for hepatitis C

     Article • Expert Opinion on Emerging Drugs, March 2008, Informa Healthcare

     Dr. Vicente Soriano

743. 
     Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

     Article • AIDS, March 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

744. 
     HIV-1 Infection in Persistently HIV-1-Seronegative Individuals: More Reasons for HIV RNA Screening

     Article • Clinical Infectious Diseases, March 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

745. 
     Lobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats

     Article • Physiology & Behavior, March 2008, Elsevier

     Dr. Vicente Soriano

746. 
     Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

     Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

747. 
     Hepatitis B virus escape mutants induced by antiviral therapy

     Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

748. 
     Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola

     Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

     Dr. Vicente Soriano

749. 
     European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

     Article • HIV Medicine, February 2008, Wiley

     Dr. Vicente Soriano

750. 
     The implications of antiviral drugs with activity against hepatitis B virus and HIV

     Article • Current Opinion in Internal Medicine, February 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

751. 
     Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

     Article • Journal of Clinical Microbiology, January 2008, ASM Journals

     Dr. Vicente Soriano

752. 
     Antiretroviral drugs and liver injury

     Article • AIDS, January 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

753. 
     Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

     Article • AIDS, January 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

754. 
     Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools

     Article • Journal of Medical Virology, January 2008, Wiley

     Dr. Vicente Soriano

755. 
     Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

     Article • AIDS, January 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

756. 
     Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance

     Article • AIDS, January 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

757. 
     Prevalence of and Risk Factors for Hepatitis B Virus Infection among Street-Recruited Young Injection and Non-Injection Heroin Users in Barcelona, Madrid and Seville

     Article • European Addiction Research, January 2008, Karger Publishers

     Dr. Vicente Soriano

758. 
     Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

     Article • AIDS, January 2008, Wolters Kluwer Health

     Dr. Vicente Soriano

759. 
     698 NUCLEOS(T)IDE ANALOGUE TREATMENT FOR HBV INFECTIONS CAN RESULT IN THE SELECTION OF POSSIBLE HBV VACCINE ESCAPE MUTANTS

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

760. 
     770 HCV RELAPSES UPON COMPLETION OF PEG-INTERFERON PLUS RIBAVIRIN IN HIV-INFECTED PATIENTS: RATE, TIMING AND PREDICTORS

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

761. 
     801 RESCUE THERAPY WITH OPTIMIZED PEG-INTERFERON PLUS RIBAVIRIN IN HIV/HCV COINFECTED PATIENTS: CRITICAL ROLE OF RIBAVIRIN PLASMA LEVELS IN THE PILOT-NR TRIAL

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

762. 
     838 DISTINCT HEPATITIS C VIRUS KINETICS IN HIV+ PATIENTS TREATED WITH RIBAVIRIN PLUS EITHER PEGYLATED INTERFERON ALFA-2A OR ALFA-2B

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

763. 
     708 POLYMORPHISMS WHICH MAY BE RESPONSIBLE FOR PRIMARY TREATMENT FAILURE TO ADEFOVIR IN DISTINCT HEPATITIS B VIRUS GENOTYPES

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

764. 
     606 RELATIONSHIP BETWEEN THE STAGE OF LIVER FIBROSIS AND REGULATORY T (TREG) CELLS IN PATIENTS WITH CHRONIC HEPATITIS C COINFECTED WITH HIV

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

765. 
     The changing epidemiology of hepatitis C virus infection in Europe

     Article • Journal of Hepatology, January 2008, Elsevier

     Dr. Vicente Soriano

766. 
     Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years

     Article • Journal of Antimicrobial Chemotherapy, December 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

767. 
     Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2007, Wolters Kluwer Health

     Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano, Dr Frank van Leth

768. 
     Measurement of Ribavirin Plasma Concentrations by High-performance Liquid Chromatography Using a Novel Solid-phase Extraction Method in Patients Treated for Chronic Hepatitis C

     Article • Therapeutic Drug Monitoring, December 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

769. 
     Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

     Article • Journal of Antimicrobial Chemotherapy, November 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

770. 
     Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

     Article • AIDS, November 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

771. 
     Human T Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis in an HIV-Positive Patient Coinfected with Human T Lymphotropic Virus Type 2 Following Initiation of Antiretroviral Therapy

     Article • Clinical Infectious Diseases, November 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

772. 
     Management and therapy of chronic hepatitis C in HIV

     Article • Current Opinion in HIV and AIDS, November 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

773. 
     Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

774. 
     Value of the HLA-B*5701 Allele to Predict Abacavir Hypersensitivity in Spaniards

     Article • AIDS Research and Human Retroviruses, November 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

775. 
     Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report

     Article • Clinical Rheumatology, October 2007, Springer Science + Business Media

     Dr. Vicente Soriano

776. 
     Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

     Article • Journal of Antimicrobial Chemotherapy, October 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

777. 
     Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors

     Article • Journal of Antimicrobial Chemotherapy, October 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

778. 
     Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

     Article • AIDS Research and Human Retroviruses, October 2007, Mary Ann Liebert Inc

     Dr Victor Asensi, Dr. Vicente Soriano

779. 
     Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C

     Article • Medicina Clínica, October 2007, Elsevier

     Dr. Vicente Soriano

780. 
     Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses

     Article • AIDS, October 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

781. 
     Large lymphadenopathies complicating the abacavir hypersensitivity reaction

     Article • AIDS, October 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

782. 
     Short Communication: Dynamics of Drug-Resistant HIV-1 in Plasma and Peripheral Blood Cells in Patients during and after Enfuvirtide Therapy

     Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

     Dr Dimitrios Paraskevis, Dr. Vicente Soriano

783. 
     Amino Acid Conservation in the gp41 Transmembrane Protein and Natural Polymorphisms Associated with Enfuvirtide Resistance across HIV-1 Variants

     Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

784. 
     Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients

     Article • The Journal of Infectious Diseases, September 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

785. 
     Short Communication: Hospital-Based Surveillance for HTLV-1/2 Infections in Spain

     Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Enrique J. Calderon

786. 
     Estavudina en el tratamiento antirretroviral

     Article • Medicina Clínica, September 2007, Elsevier

     Dr. Vicente Soriano

787. 
     Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome

     Article • Journal of Viral Hepatitis, August 2007, Wiley

     Dr. Vicente Soriano

788. 
     Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus

     Article • Clinical Rheumatology, August 2007, Springer Science + Business Media

     Dr. Vicente Soriano

789. 
     Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

790. 
     Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

     Article • AIDS Research and Human Retroviruses, August 2007, Mary Ann Liebert Inc

     Dr Victor Asensi, Dr. Vicente Soriano

791. 
     Escape Mutations in HIV Infection and its Impact on CD8+ T Cell Responses

     Article • Current Molecular Medicine, August 2007, Bentham Science Publishers

     Dr. Vicente Soriano

792. 
     Authors?? Reply to ???How Safe Is Unprotected Sex Between Discordant Couples to Conceive in the Highly Active Antiretroviral Therapy Era????

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

793. 
     Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

     Article • Expert Opinion on Investigational Drugs, August 2007, Informa Healthcare

     Dr. Vicente Soriano

794. 
     Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

     Article • Journal of Antimicrobial Chemotherapy, July 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

795. 
     Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, July 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

796. 
     Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

     Article • AIDS, July 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

797. 
     Impact of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy

     Article • AIDS Research and Human Retroviruses, July 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

798. 
     Is natural conception a valid option for HIV-serodiscordant couples?

     Article • Human Reproduction, June 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

799. 
     Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

     Article • BMC Infectious Diseases, June 2007, Springer Science + Business Media

     Dr. Vicente Soriano

800. 
     Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

     Article • Infection Genetics and Evolution, June 2007, Elsevier

     Dr. Vicente Soriano

801. 
     Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

     Article • Journal of Viral Hepatitis, June 2007, Wiley

     Dr. Vicente Soriano

802. 
     Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients

     Article • Journal of Viral Hepatitis, June 2007, Wiley

     Dr. Vicente Soriano

803. 
     Infección por el virus de la inmunodeficiencia humana tipo 2 y virus linfotrópicos humanos tipos 1 y 2 en España

     Article • Medicina Clínica, June 2007, Elsevier

     Enrique J. Calderon, Dr. Vicente Soriano

804. 
     Liver Fibrosis Stage and HCV Genotype Distribution in HIV–HCV Coinfected Patients with Persistently Normal Transaminases

     Article • AIDS Research and Human Retroviruses, June 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

805. 
     Consejo reproductivo en parejas serodiscordantes para el virus de la inmunodeficiencia humana

     Article • Medicina Clínica, June 2007, Elsevier

     Dr. Vicente Soriano

806. 
     Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation

     Article • Clinical & Experimental Immunology, May 2007, Wiley

     Dr. Vicente Soriano

807. 
     Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel

     Article • AIDS, May 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

808. 
     Telbivudine: a new option for the treatment of chronic hepatitis B

     Article • Expert Opinion on Biological Therapy, May 2007, Informa Healthcare

     Dr. Vicente Soriano

809. 
     C2-Symmetric Bissulfoxides as Organocatalysts in the Allylation of Benzoyl Hydrazones:  Spacer and Concentration Effects

     Article • Organic Letters, May 2007, American Chemical Society (ACS)

     Dr. Vicente Soriano

810. 
     Evolution of T-cell Responses to Hepatitis C Virus (HCV) during Pegylated Interferon plus Ribavirin treatment in HCV-Monoinfected and in HCV/HIV-Coinfected Patients

     Article • Antiviral Therapy, May 2007, SAGE Publications

     Dr. Vicente Soriano

811. 
     Treatment of Chronic Hepatitis B or C in HIV‐Infected Patients with Dual Viral Hepatitis

     Article • The Journal of Infectious Diseases, April 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

812. 
     CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load

     Article • Journal of Antimicrobial Chemotherapy, April 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano, annalisa de silvestri

813. 
     Hepatitis B Virus Genotypes and Lamivudine Resistance Mutations in HIV/Hepatitis B Virus-Coinfected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

814. 
     [591] IMPACT OF ANEMIA AND ZIDOVUDINE USE ON SUSTAINED VIROLOGICAL RESPONSE IN A TRIAL OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

     Article • Journal of Hepatology, April 2007, Elsevier

     Dr Victor Asensi, Dr. Vicente Soriano

815. 
     Evaluation of performance across the dynamic range of the Abbott RealTime™ HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses

     Article • Journal of Virological Methods, April 2007, Elsevier

     Dr. Vicente Soriano

816. 
     Influence of Liver Fibrosis Stage on Plasma Levels of Antiretroviral Drugs in HIV‐Infected Patients with Chronic Hepatitis C

     Article • The Journal of Infectious Diseases, April 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

817. 
     Introduction of Non-B Subtypes among Spaniards Newly Diagnosed with HIV Type 1 in the Canary Islands

     Article • AIDS Research and Human Retroviruses, April 2007, Mary Ann Liebert Inc

     Dr. Vicente Soriano

818. 
     Outbreak of Syphilis, but Not of Acute Hepatitis C, Among HIV-Infected Homosexual Men in Madrid

     Article • HIV Clinical Trials, April 2007, Taylor & Francis

     Dr. Vicente Soriano

819. 
     Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

     Article • Expert Opinion on Pharmacotherapy, April 2007, Informa Healthcare

     Dr. Vicente Soriano

820. 
     [188] INFLUENCE OF ANTIRETROVIRALS IN THE PROGRESSION OF LIVER FIBROSIS IN HIV/HCV COINFECTED PATIENT S. EFFECT OF HEPATOTOXICITY AND METABOLIC ABNORMALITIES

     Article • Journal of Hepatology, April 2007, Elsevier

     Dr. Vicente Soriano

821. 
     [512] HEPATITIS B VIRUS MUTANTS IN PATIENTS FAILING ANTIRETROVIRALS WITH ANTI-HBV ACTIVITY: IMPLICATIONS FOR DIAGNOSTICS AND VACCINE ESCAPE

     Article • Journal of Hepatology, April 2007, Elsevier

     Dr. Vicente Soriano

822. 
     [616] BASELINE HCVRNA AND RAPID VIROLOGICAL DECAY ARE THE MAIN PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN HIV-HCV COINFECTED PATIENTS

     Article • Journal of Hepatology, April 2007, Elsevier

     Dr. Vicente Soriano

823. 
     [697] LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITHOUT CHRONIC VIRAL HEPATITIS. PREVALENCE, CLINICAL CHARACTERISTICS AND POTENTIAL CAUSES

     Article • Journal of Hepatology, April 2007, Elsevier

     Dr. Vicente Soriano

824. 
     Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

     Article • Expert Opinion on Pharmacotherapy, March 2007, Informa Healthcare

     Dr. Vicente Soriano

825. 
     Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

     Article • AIDS, March 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

826. 
     Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients

     Article • AIDS, March 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

827. 
     P1899 Assessment of liver cirrhosis by elastography in HCV/HIV co–infected patients

     Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

     Dr. Vicente Soriano

828. 
     Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

     Article • Journal of Antimicrobial Chemotherapy, February 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

829. 
     Recomendaciones españolas sobre el uso adecuado de enfuvirtida

     Article • Enfermedades Infecciosas y Microbiología Clínica, February 2007, Elsevier

     Dr. Vicente Soriano

830. 
     Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

     Article • Journal of Infection, February 2007, Elsevier

     Dr. Vicente Soriano

831. 
     Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma

     Article • European Journal of Immunology, February 2007, Wiley

     Dr. Vicente Soriano

832. 
     Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide

     Article • Journal of Clinical Virology, February 2007, Elsevier

     Dr. Vicente Soriano

833. 
     Adult neurogenesis and schizophrenia: A window on abnormal early brain development?

     Article • Schizophrenia Research, February 2007, Elsevier

     Dr. Vicente Soriano

834. 
     Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

     Article • Drug Metabolism Letters, January 2007, Bentham Science Publishers

     Dr. Vicente Soriano

835. 
     Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

     Article • AIDS, January 2007, Wolters Kluwer Health

     Dr. Vicente Soriano

836. 
     Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus

     Article • Journal of Medical Virology, January 2007, Wiley

     Dr. Vicente Soriano

837. 
     Influence of Human T Cell Lymphotropic Virus Type 2 Coinfection on Virological and Immunological Parameters in HIV Type 1–Infected Patients

     Article • Clinical Infectious Diseases, January 2007, Oxford University Press (OUP)

     Dr. Vicente Soriano

838. 
     Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy “don’t ask, draw a blood sample, vaccinate and try to schedule another visit”

     Article • Journal of Clinical Virology, January 2007, Elsevier

     Dr. Vicente Soriano

839. 
     Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

     Article • Journal of Medical Virology, January 2007, Wiley

     Dr. Vicente Soriano

840. 
     Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): metodología y primeros resultados

     Article • Enfermedades Infecciosas y Microbiología Clínica, January 2007, Elsevier

     Dr. Vicente Soriano

841. 
     Aplicación de modelos estructurales marginales para estimar los efectos de la terapia antirretroviral en 5 cohortes de seroconvertores al virus de la inmunodeficiencia humana

     Article • Gaceta Sanitaria, January 2007, Elsevier

     Dr. Vicente Soriano

842. 
     Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression

     Article • Virus Genes, December 2006, Springer Science + Business Media

     Dr. Vicente Soriano

843. 
     Rate of Virologic Failure and Selection of Drug Resistance Mutations Using Different Triple Nucleos(t)ide Analogue Combinations in HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, December 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

844. 
     Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002

     Article • Journal of Viral Hepatitis, December 2006, Wiley

     Dr. Vicente Soriano

845. 
     Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1.1)

     Article • Journal of Clinical Microbiology, November 2006, ASM Journals

     Dr. Vicente Soriano

846. 
     Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

847. 
     Coinfection with Hepatitis C Virus Increases Lymphocyte Apoptosis in HIV-Infected Patients

     Article • Clinical Infectious Diseases, November 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

848. 
     Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

     Article • AIDS, November 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

849. 
     Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges

     Article • The Journal of Infectious Diseases, October 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

850. 
     Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

     Article • AIDS, October 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

851. 
     Implicaciones diagnósticas, clínicas y terapéuticas de las hepatitis virales en el paciente infectado por el VIH

     Article • Enfermedades Infecciosas y Microbiología Clínica, October 2006, Elsevier

     Dr. Vicente Soriano

852. 
     Infecciones por VIH-2 y HTLV-1/2 en España

     Article • Enfermedades Infecciosas y Microbiología Clínica, October 2006, Elsevier

     Dr. Vicente Soriano

853. 
     Tratamiento de la hepatitis crónica B en pacientes infectados por el VIH

     Article • Gastroenterología y Hepatología, October 2006, Elsevier

     Dr. Vicente Soriano

854. 
     Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

     Article • HIV Clinical Trials, October 2006, Taylor & Francis

     Dr. Vicente Soriano

855. 
     Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors

     Article • Epidemiology and Infection, September 2006, Cambridge University Press

     Dr. Vicente Soriano

856. 
     Impact of Antiretroviral Treatment-Related Toxicities on Hospital Admissions in HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

857. 
     Impact of Gag Sequence Variability on Level, Phenotype, and Function of Anti-HIV Gag-Specific CD8+ Cytotoxic T Lymphocytes in Untreated Chronically HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

858. 
     ¿Se debería recomendar el cribado de la infección por el virus linfotrópico humano de células T de tipo 1 en las mujeres embarazadas?

     Article • Progresos de Obstetricia y Ginecología, September 2006, Sociedad Espanola de Nutricion Parenteral y Enteral (SENPE)

     Dr. Vicente Soriano

859. 
     Virological Outcome of Chronic Hepatitis B Virus Infection in HIV-Coinfected Patients Receiving Anti-HBV Active Antiretroviral Therapy

     Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

860. 
     Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus

     Article • Archives of Internal Medicine, August 2006, American Medical Association (AMA)

     Dr. Vicente Soriano, Dr Frank van Leth

861. 
     Immunological and Virological Effects of Structured Treatment Interruptions following Exposure to Hydroxyurea Plus Didanosine

     Article • AIDS Research and Human Retroviruses, August 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

862. 
     Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure

     Article • Journal of Clinical Virology, August 2006, Elsevier

     Dr. Vicente Soriano

863. 
     Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients

     Article • HIV Clinical Trials, August 2006, Taylor & Francis

     Dr. Vicente Soriano

864. 
     Mutations affecting the replication capacity of the hepatitis B virus

     Article • Journal of Viral Hepatitis, July 2006, Wiley

     Dr. Vicente Soriano

865. 
     Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors

     Article • AIDS, July 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

866. 
     Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

867. 
     HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

     Article • AIDS, June 2006, Wolters Kluwer Health

     Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

868. 
     Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes

     Article • Journal of Epidemiology & Community Health, June 2006, BMJ

     Dr. Vicente Soriano

869. 
     Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART

     Article • AIDS, June 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

870. 
     Coinfección por el VIH y el virus de la hepatitis C

     Article • Enfermedades Infecciosas y Microbiología Clínica, May 2006, Elsevier

     Dr. Vicente Soriano

871. 
     Management of chronic hepatitis B and C in HIV-coinfected patients

     Article • Journal of Antimicrobial Chemotherapy, May 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

872. 
     External Validation of Atazanavir/Ritonavir Genotypic Score in HIV-1 Protease Inhibitor-Experienced Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

873. 
     Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir

     Article • AIDS Research and Human Retroviruses, April 2006, Mary Ann Liebert Inc

     Dr. Vicente Soriano

874. 
     Predictors of Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C Virus (HCV) Infection: Assessment Using Transient Elastometry and the Role of HCV Genotype 3

     Article • Clinical Infectious Diseases, April 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

875. 
     Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

     Article • AIDS, April 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

876. 
     574 Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients

     Article • Journal of Hepatology, April 2006, Elsevier

     Dr. Vicente Soriano

877. 
     421 Hepatitis C virus (HCV)-specific CD4+ and CD8+ T cell responses in patients with chronic hepatitis C treated with pegylated interferon plus ribavirin

     Article • Journal of Hepatology, April 2006, Elsevier

     Dr. Vicente Soriano

878. 
     Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir

     Article • Journal of Antimicrobial Chemotherapy, March 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

879. 
     The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

880. 
     Chronic Hepatitis C in HIV-Infected Patients: Those Who More Need Therapy are Those Who Respond Less

     Article • Infectious Disorders - Drug Targets, March 2006, Bentham Science Publishers

     Dr. Vicente Soriano

881. 
     Entrada del virus de la inmunodeficiencia humana en las células: mecanismos y posibilidades terapéuticas

     Article • Medicina Clínica, March 2006, Elsevier

     Dr. Vicente Soriano

882. 
     HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates

     Article • Journal of Clinical Virology, March 2006, Elsevier

     Dr. Vicente Soriano

883. 
     Standard of Care for HCV/HIV-Coinfected Patients

     Article • Journal of Chemotherapy, March 2006, Taylor & Francis

     Dr. Vicente Soriano

884. 
     HIV entry inhibitors: mechanisms of action and resistance pathways

     Article • Journal of Antimicrobial Chemotherapy, February 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

885. 
     Overview of the pharmacogenetics of HIV therapy

     Article • The Pharmacogenomics Journal, February 2006, Springer Science + Business Media

     Dr. Vicente Soriano

886. 
     Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy

     Article • Journal of Antimicrobial Chemotherapy, February 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

887. 
     Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

     Article • Antimicrobial Agents and Chemotherapy, February 2006, ASM Journals

     Dr. Vicente Soriano

888. 
     Effectiveness and Safety of Abacavir, Lamivudine, and Zidovudine in Antiretroviral Therapy-Naive HIV-Infected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

889. 
     Tratamiento antirretroviral en la infección por el virus de la inmunodeficiencia humana: ¿cuánto dura su eficacia?

     Article • Medicina Clínica, February 2006, Elsevier

     Dr. Vicente Soriano

890. 
     Respuesta de los autores

     Article • Medicina Clínica, February 2006, Elsevier

     Dr. Vicente Soriano

891. 
     Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons

     Article • AIDS, February 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

892. 
     Variability in the P6gag domains of HIV-1 involved in viral budding

     Article • AIDS, February 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

893. 
     Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1

     Article • Clinical Infectious Diseases, January 2006, Oxford University Press (OUP)

     Dr. Vicente Soriano

894. 
     High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART

     Article • AIDS, January 2006, Wolters Kluwer Health

     Dr. Vicente Soriano

895. 
     Can the Level of Immunosuppression in Human Immunodeficiency Virus-Infected Patients Affect the Reliability of Human T-Cell Lymphotropic Virus Type 2 Serological Diagnosis?

     Article • Clinical and Vaccine Immunology, January 2006, ASM Journals

     Dr. Vicente Soriano

896. 
     Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain

     Article • Journal of Medical Virology, January 2006, Wiley

     Dr. Vicente Soriano

897. 
     Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

     Article • Scandinavian Journal of Infectious Diseases, January 2006, Taylor & Francis

     Dr. Vicente Soriano

898. 
     Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates

     Article • Journal of Hepatology, January 2006, Elsevier

     Dr. Vicente Soriano

899. 
     Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

     Article • HIV Clinical Trials, January 2006, Taylor & Francis

     Dr. Vicente Soriano

900. 
     CD4+T Cell Recovery beyond the First Year of Complete Suppression of Viral Replication during Highly Active Antiretroviral Therapy Is Not Influenced by CD8+T Cell Activation

     Article • The Journal of Infectious Diseases, December 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

901. 
     Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

     Article • AIDS, December 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

902. 
     Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

     Article • Journal of Clinical Virology, December 2005, Elsevier

     Dr. Vicente Soriano

903. 
     Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center

     Article • HIV Clinical Trials, December 2005, Taylor & Francis

     Dr. Vicente Soriano

904. 
     Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

     Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano, Dr Frank van Leth, Prof Robert Colebunders

905. 
     NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder

     Article • Schizophrenia Research, December 2005, Elsevier

     Dr. Vicente Soriano

906. 
     New paradigms in the management of HIV and hepatitis C virus coinfection

     Article • Current Opinion in Infectious Diseases, December 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

907. 
     Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors

     Article • Retrovirology, December 2005, Springer Science + Business Media

     Dr. Vicente Soriano

908. 
     Complications in treating chronic hepatitis B in patients with HIV

     Article • Expert Opinion on Pharmacotherapy, November 2005, Informa Healthcare

     Dr. Vicente Soriano

909. 
     Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

     Article • AIDS, November 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

910. 
     Genetic Analysis of Regulatory, Promoter, and TAR Regions of LTR Sequences Belonging to HIV Type 1 Non-B Subtypes

     Article • AIDS Research and Human Retroviruses, November 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

911. 
     Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

     Article • Clinical Infectious Diseases, November 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

912. 
     Effect of Ribavirin on Intracellular and Plasma Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Results of a Randomized Clinical Study

     Article • Antimicrobial Agents and Chemotherapy, October 2005, ASM Journals

     Dr. Vicente Soriano

913. 
     Differences in the Length of Gag Proteins among Different HIV Type 1 Subtypes

     Article • AIDS Research and Human Retroviruses, October 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

914. 
     Failure of Hepatitis C Therapy in HIV‐Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype

     Article • The Journal of Infectious Diseases, October 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

915. 
     Hepatic and Renal Safety Profile of Tenofovir in HIV-Infected Patients with Hepatitis C, Including Patients on Interferon Plus Ribavirin

     Article • HIV Clinical Trials, October 2005, Taylor & Francis

     Dr. Vicente Soriano

916. 
     Sustained Virological Response following HCV Therapy is Associated with Non-Progression of Liver Fibrosis in HCV/HIV-Coinfected Patients

     Article • Antiviral Therapy, October 2005, SAGE Publications

     Dr. Vicente Soriano

917. 
     Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

     Article • The Journal of Infectious Diseases, September 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

918. 
     Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

     Article • The Journal of Infectious Diseases, September 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

919. 
     Superiority of Protease Inhibitors over Nonnucleoside Reverse-Transcriptase Inhibitors when Highly Active Antiretroviral Therapy Is Resumed after Treatment Interruption

     Article • Clinical Infectious Diseases, September 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

920. 
     Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group

     Article • Haemophilia, September 2005, Wiley

     Dr. Vicente Soriano

921. 
     Clinical benefit of interventions driven by therapeutic drug monitoring

     Article • HIV Medicine, September 2005, Wiley

     Dr. Vicente Soriano

922. 
     HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003

     Article • HIV Medicine, September 2005, Wiley

     Dr. Vicente Soriano

923. 
     Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

     Article • AIDS Research and Human Retroviruses, September 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

924. 
     Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

     Article • Journal of Clinical Microbiology, August 2005, ASM Journals

     Dr. Vicente Soriano

925. 
     Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

926. 
     Reductions in Stavudine Dose Might Ameliorate Mitochondrial-Associated Complications Without Compromising Antiviral Activity

     Article • HIV Clinical Trials, August 2005, Taylor & Francis

     Dr. Vicente Soriano

927. 
     Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1

     Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

928. 
     Viral Response to Antiretroviral Therapy in a Patient Coinfected with HIV Type 1 and Type 2

     Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

929. 
     Erratum

     Article • The Lancet Infectious Diseases, July 2005, Elsevier

     Dr. Vicente Soriano

930. 
     Liver Transplantation in HIV–HCV Coinfected Candidates: What Is the Most Appropriate Time for Evaluation?

     Article • AIDS Research and Human Retroviruses, July 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

931. 
     Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma

     Article • Journal of Virological Methods, July 2005, Elsevier

     Dr. Vicente Soriano

932. 
     Treatment Response and Drug Resistance in Patients Infected with HIV Type 1 Group O Viruses

     Article • AIDS Research and Human Retroviruses, July 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

933. 
     Short Communication: Changes in Nevirapine Plasma Concentrations Over Time and Its Relationship with Liver Enzyme Elevations

     Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

934. 
     Enfuvirtide Is Active against HIV Type 1 Group O

     Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

935. 
     Management of patients co-infected with hepatitis B virus and HIV

     Article • The Lancet Infectious Diseases, June 2005, Elsevier

     Dr. Vicente Soriano

936. 
     Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

     Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

937. 
     Outmoded Attitudes Toward Organ Donation Among Turkish Health Care Professionals

     Article • Transplantation Proceedings, June 2005, Elsevier

     Dr. Vicente Soriano

938. 
     Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects

     Article • Clinical Infectious Diseases, May 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

939. 
     Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

     Article • Journal of Clinical Virology, May 2005, Elsevier

     Dr. Vicente Soriano, Enrique J. Calderon

940. 
     Estrategias terapéuticas en la infección por el virus de la inmunodeficiencia humana

     Article • Medicina Clínica, May 2005, Elsevier

     Dr. Vicente Soriano

941. 
     Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

     Article • PLoS Medicine, April 2005, PLOS

     Dr. Vicente Soriano

942. 
     Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain

     Article • Journal of Medical Virology, April 2005, Wiley

     Enrique J. Calderon, Dr. Vicente Soriano

943. 
     Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

     Article • AIDS, April 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

944. 
     Interplay between hepatitis C, liver steatosis and antiretroviral therapy in HIV-infected patients

     Article • AIDS, April 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

945. 
     Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

     Article • AIDS, April 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

946. 
     Situación actual de la infección por el VIH-2 y el HTLV-1/2 en España: luces y sombras

     Article • Medicina Clínica, April 2005, Elsevier

     Dr. Vicente Soriano

947. 
     Differential Upregulation of CD38 on Different T-Cell Subsets May Influence the Ability to Reconstitute CD4+ T Cells Under Successful Highly Active Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

948. 
     Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B

     Article • HIV Clinical Trials, April 2005, Taylor & Francis

     Dr. Vicente Soriano

949. 
     Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients

     Article • Journal of Clinical Virology, April 2005, Elsevier

     Dr. Vicente Soriano

950. 
     Relationship between drug resistance mutations, plasma viremia, and CD4+T-cell counts in patients with chronic HIV infection

     Article • Journal of Medical Virology, March 2005, Wiley

     Dr. Vicente Soriano

951. 
     Regulación de la transcripción en los diferentes subtipos del VIH-1

     Article • Enfermedades Infecciosas y Microbiología Clínica, March 2005, Elsevier

     Dr. Vicente Soriano

952. 
     Risks and benefits of antiretroviral therapy in HIV–HCV co-infected patients

     Article • Journal of Hepatology, March 2005, Elsevier

     Dr. Vicente Soriano

953. 
     Association of CCR5 Human Haplogroup E with Rapid HIV Type 1 Disease Progression

     Article • AIDS Research and Human Retroviruses, February 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

954. 
     Atazanavir: The Advent of a New Generation of More Convenient Protease Inhibitors

     Article • HIV Clinical Trials, February 2005, Taylor & Francis

     Dr. Vicente Soriano

955. 
     Estimated Extent of Cross-Resistance to Ritonavir-Boosted Protease Inhibitors Among Protease Inhibitors-Experienced Patients: Implications for Tipranavir Use

     Article • AIDS Patient Care and STDs, February 2005, Mary Ann Liebert Inc

     Dr. Vicente Soriano

956. 
     Hepatitis C y VIH en prisiones españolas

     Article • Enfermedades Infecciosas y Microbiología Clínica, February 2005, Elsevier

     Dr. Vicente Soriano

957. 
     Natural history of Hymenoptera venom allergy in Eastern Spain

     Article • Clinical & Experimental Allergy, February 2005, Wiley

     Dr. Vicente Soriano

958. 
     Heterogeneous nature of HIV-1 recombinants spreading in Spain

     Article • Journal of Medical Virology, January 2005, Wiley

     Dr. Vicente Soriano

959. 
     Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

     Article • Journal of Medical Virology, January 2005, Wiley

     Dr Alejandro Vallejo, Dr. Vicente Soriano

960. 
     Hepatotoxicity of Antiretrovirals

     Article • Drug Safety, January 2005, Springer Science + Business Media

     Dr. Vicente Soriano

961. 
     Hepatitis C Virus (HCV) Genotypes and Disease Progression in HIV/HCV‐Coinfected Patients

     Article • The Journal of Infectious Diseases, January 2005, Oxford University Press (OUP)

     Dr. Vicente Soriano

962. 
     Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients

     Article • Journal of Medical Virology, January 2005, Wiley

     Dr. Vicente Soriano

963. 
     The Seroepidemiology of Human T-Lymphotropic Viruses

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2005, Wolters Kluwer Health

     Dr. Vicente Soriano

964. 
     Absceso cerebral en paciente inmunodeprimida

     Article • Enfermedades Infecciosas y Microbiología Clínica, January 2005, Elsevier

     Dr. Vicente Soriano

965. 
     Short Communication: Benefits in the Lipid Profile after Substitution of Abacavir for Stavudine: A 48-Week Prospective Study

     Article • AIDS Research and Human Retroviruses, December 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

966. 
     Hepatocellular carcinoma in HIV-infected patients

     Article • AIDS, November 2004, Wolters Kluwer Health

     Dr Victor Asensi, Dr. Vicente Soriano

967. 
     Avances en el diagnóstico y tratamiento de la infección por el virus de la hepatitis B

     Article • Enfermedades Infecciosas y Microbiología Clínica, November 2004, Elsevier

     Dr. Vicente Soriano

968. 
     Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes

     Article • Journal of Clinical Virology, November 2004, Elsevier

     Dr. Vicente Soriano

969. 
     Evidence for Differences in the Sexual Transmission Efficiency of HIV Strains with Distinct Drug Resistance Genotypes

     Article • Clinical Infectious Diseases, October 2004, Oxford University Press (OUP)

     Dr. Vicente Soriano

970. 
     Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain

     Article • Journal of Medical Virology, October 2004, Wiley

     Dr. Vicente Soriano

971. 
     Comments on the review ‘Care of patients with hepatitis C and HIV co-infection’ by Soriano et al.

     Article • AIDS, October 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

972. 
     Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals

     Article • Journal of Virological Methods, October 2004, Elsevier

     Dr. Vicente Soriano

973. 
     Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations

     Article • AIDS, October 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

974. 
     How effective is HAART in HCV and HIV coinfection?

     Article • AIDS, October 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

975. 
     Predictors of selection of K65R

     Article • AIDS, October 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

976. 
     Reply to Bruno et al.

     Article • AIDS, October 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

977. 
     Failure to Detect Human Immunodeficiency Virus Type 1 Superinfection in 28 HIV-Seroconcordant Individuals with High Risk of Reexposure to the Virus

     Article • AIDS Research and Human Retroviruses, September 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

978. 
     Triple-Nucleoside Regimens versus Efavirenz

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2004, New England Journal of Medicine (NEJM/MMS)

     Dr. Vicente Soriano

979. 
     Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

     Article • Current Drug Metabolism, August 2004, Bentham Science Publishers

     Dr. Vicente Soriano

980. 
     New Hopes for HIV and HCV Coinfection in 2004

     Article • HIV Clinical Trials, August 2004, Taylor & Francis

     Dr. Vicente Soriano

981. 
     Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

     Article • HIV Clinical Trials, August 2004, Taylor & Francis

     Dr. Vicente Soriano

982. 
     Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

     Article • Journal of Medical Virology, July 2004, Wiley

     Dr. Vicente Soriano

983. 
     Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

     Article • The Lancet, July 2004, Elsevier

     Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano

984. 
     Short Communication: Liver Toxicity of Lopinavir-Containing Regimens in HIV-Infected Patients with or without Hepatitis C Coinfection

     Article • AIDS Research and Human Retroviruses, July 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

985. 
     Reply

     Article • Clinical Infectious Diseases, June 2004, Oxford University Press (OUP)

     Dr. Vicente Soriano

986. 
     Predictors of Severe Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C

     Article • Clinical Infectious Diseases, June 2004, Oxford University Press (OUP)

     Dr. Vicente Soriano

987. 
     CD4+ T-Cell Gain With Nonnucleoside or Protease Inhibitors: Convenience May Not Always Be the Most Convenient

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

988. 
     Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

     Article • AIDS, June 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

989. 
     Impact of Chronic Hepatitis C on HIV-1 Disease Progression

     Article • HIV Clinical Trials, June 2004, Taylor & Francis

     Dr. Vicente Soriano

990. 
     Tolerance of Didanosine as Enteric-Coated Capsules versus Buffered Tablets

     Article • AIDS Patient Care and STDs, June 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

991. 
     Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide

     Article • AIDS, May 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

992. 
     Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

     Article • AIDS, May 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

993. 
     Hepatitis C Virus (HCV) Relapses after Anti-HCV Therapy Are More Frequent in HIV-Infected Patients

     Article • AIDS Research and Human Retroviruses, April 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

994. 
     Tenofovir-related nephrotoxicity in HIV-infected patients

     Article • AIDS, April 2004, Wolters Kluwer Health

     Dr. Vicente Soriano

995. 
     Prevalencia de infección por virus de transmisión parenteral en consumidores actuales de heroína de 3 ciudades españolas

     Article • Medicina Clínica, April 2004, Elsevier

     Dr. Vicente Soriano

996. 
     Simplificación de los regímenes antirretrovíricos. Una necesidad para garantizar el control de la infección por VIH a largo plazo

     Article • Revista Clínica Española, April 2004, Elsevier

     Dr. Vicente Soriano

997. 
     Infecciones por VIH-2 y HTLV-I/II en España

     Article • Enfermedades Infecciosas y Microbiología Clínica, March 2004, Elsevier

     Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon

998. 
     Are Fusion Inhibitors Active against All HIV Variants?

     Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

999. 
     Changes in Mitochondrial DNA Copy Number in Blood Cells from HIV-Infected Patients Undergoing Antiretroviral Therapy

     Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

     Dr. Vicente Soriano

1000. 
      Prediction of Virological Response to Lopinavir/Ritonavir Using the Genotypic Inhibitory Quotient

      Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

      Dr. Vicente Soriano